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ABSTRACT 
The power of a biomedical imaging modality can be augmented and is, in large part, 
determined by the capabilities of the available contrast agents. For example, quantum 
dots represent a colorful palette of powerful contrast agents for optical fluorescence 
imaging and Raman spectroscopy, given their tunable multiplexing capability and long-
term stability compared to traditional organic molecule-based fluorescent labels. On the 
contrary, as the workhorses in both clinical and research imaging, the full potentials of 
magnetic resonance imaging and computed tomography have yet to be actualized due to 
several existing fundamental limitations in the currently available contrast agents, 
including but not limited to, the lack of multiplexing capability, low sensitivity, as well as 
the lack of functional imaging capacity. Leveraging both traditional top-down micro- and 
nanoelectromechanical systems fabrication techniques and bottom-up self-assembly 
approaches, this dissertation explores the possibility of mitigating these limitations by 
engineering precisely controllable, size and shape (as well as a host of other materials 
properties) specific micro- and nanoparticles, for use as the next generation contrast 
agents for magnetic resonance imaging and computed tomography. 
X 
Herein, the ways by which engineering approaches can impact the design, 
fabrication and characterization of contrast agents is investigated. Specifically, different 
configmations of magnetic micro- and nanoparticles, including double-disk and hollow-
cylinder structmes, fabricated using a top-down approach were employed as magnetic 
resonance imaging contrast agents enabled with a multiplexing capability and improved 
sensitivity. Subsequently, a scalable nanomanufactming platform, utilizing nanoporous 
anodized aluminum oxide membranes as templates for pattern transfer as well as 
thermal/ultraviolet nanoimprinting techniques, was developed for the high throughput 
fabrication of size and shape specific polymeric nanorods. When ladened with X-ray 
attenuating tantalum oxide nanoparticle payloads, these polymeric nanorods can be used 
as contrast agents for computed tomography, yielding prolonged vascular circulation 
times, improved sensitivity, as well as targeted imaging capabilities. Furthermore, by 
applying various payload materials, this nanomanufacturing platform also has the 
flexibility to produce contrast agents for other imaging modalities, as well as the potential 
to realize dual-purpose agents for both diagnostic and therapeutic applications. 
Xl 
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A .................................... .... .. ... ...... .............. ..... ... .. Angstrom, unit of length 
Al· .. ... .................... . .. . ................................................... . .... . ... .. Aluminum 
Ar ········· · ···························· ··· · ·· · · ·· · ·· · · ·· ····· · ·· · · · ······ ·· ··· ····· ········ · ··· ··Argon 
Au··········· · ··· · · ·· ··························· · ········ · ······· · · ·· ····················· ······ ····Gold 
Bo· ..... .................. .... .. . ... . ............... . .................. Extemal static magnetic field 
BJ· ........ .. . . ...... . ....... . ...... . ..... ... .... . . .. . . ... . .. . .. . .... Radio frequency magnetic field 
Ba ····· · ··· · · · ···· ··· ····································································· ·· ·····Barium 
Bi · ··········· · ······· ·· ········· · ·········· · · ··· ···· · ··· · ············ ·· ·········· · · · · ·· ········ Bismuth 
BhS3 ..... .. . . .............. ... . . ........ ... . .. . . .... . . .. ........................ Bismuth (III) sulfide 
C· . . . .... ............. . . ... ... .. . . ... .. .................................. Celsius, unit of temperature 
c2H2o4 ...................................................................... .. . .. .. .. ..... Oxalic acid 
CaCb .. ... . .............. . .. ...... .. . ...... . .. . ...... .. . . .. .... . .. . .. ..... . ......... Calcium chloride 
CBrF3 . . .•.. ..... . .................... . ..... . ... .. . ... ... . ................... Bromotrifluoromethane 
CdSe ..... . .. . ... . . . .. .. ..................................................... . ... .. Cadmium selenide 
XXVll 
CF4·· ·· ·· ····· ······· · ·· · ························· · · ·· ················· · ·········· Tetrafluoromethane 
CHF3 · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·. · · · · · · · · · · · · · · · · · · · · · Trifluoromethane 
Ch · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Chlorine 
COz · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Carbon dioxide 
Cr· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·······Chromium 
emu · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ··· · ·· · Unit of magnetic moment 
e V · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ···· · ·· Electron volt 
FDTS · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · 1H,1H,2H,2H-perfluorodecyl-trichloro silane 
Fe····· .·. ···· ··· · · ·················· ······· ·· · · ············· · ···· · ·· · ·· · · ·· ··· · ······ · ··· Elemental iron 
FeOx · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Iron oxide 
G · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Gauss, unit of magnetic flux density 
h · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ~ · · · · · · · ··Disk thickness of the double-disk particle 
H · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Height of the hollow-cylinder particle 
Hz · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ····Hydrogen 
HzOz · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Hydrogen peroxide 
HzS04· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Sulfuric acid 
H3P04 · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Phosphoric acid 
He···· · · ·· ······································· ·· ············ · ·· · · · ·· ·· ··· · ·· ·· ··· · · · ·· ······ · ·Helium 
HF · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Hydrofluoric acid 
HMDS · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Hexamethyldisilazane 
IP A··· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Isopropanol 
Js · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Saturation magnetic polarization 
xxvm 
K · · · · · · · · · · · · ·· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·· · · · · · · ·; · · · · · · ·······Kelvin, unit of temperature 
keY. · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Kilo electronvolt, unit for electron energy 
KHz········· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Kilohertz, unit for frequency 
KOH · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Potassium hydroxide 
kVp · · · · · · · · · · · · · ·· · · · · · · · · · · · · · · · · · · · · · · · · · · ···· · ··Peak kilovoltage, unit for X-ray energy level 
M · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·······Molar, 1 mol/L, unit of concentration 
Mo · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Net magnetization vector 
rnA · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Milliampere, unit for current 
mAs· ·· ··············· ·· · · ······ · ··············· Milliampere-second, unit for X-ray energy level 
mW ·· · ······ ····· ······· · ······· ··· ·············· ········ ·· ··· ··· ······ ·· ·· · · ·· ··· · · · ···· ··· Milliwatts 
MHz · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·Megahertz, unit for frequency 
MIBK · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ··· · ···Methyl isobutyl ketone 
mL · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·······Milliliter, unit for volume 
mM· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Millimolar, unit for concentration 
Mxy · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Transverse magnetization vector 
Mz · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Longitudinal magnetization vector 
P . d .. N(H) · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · roton sp1n ens1t1es 
N2 · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · Nitrogen 
Na······ · ·········· ·· · ·· ··· · ··································· · ······· · ·· · ·· · ···· · ··· · ········ · Sodium 
NaOH· ··· ·· · ·· · ··· ·· · ··· ···· ··· ·· ····· ··· ···· ··· ··· ····· ·· ··· ··· ···· ·· · · ···· ····· · Sodium hydroxide 
nm· ···· ··· ··· ··· ······ · ··· · · · · ·· · ·· · · ··· ··· ··· · · · · · ·· · · · ··· · · ··············Nanometer, unit of length 
02 ······· ·· · ·· ······················································· · ··· · ··············· ··· ····Oxygen 
XXlX 
Oe 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Oersted, unit for magnetic field strength 
p AAO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 ° Polyacrylic acid 
PDMS 0 0. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 · 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 Polydimethylsiloxane 
PEG 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Polyethylene glycol 
PEG-DA· 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 Polyethylene glycol diacrylate 
PEG-DMA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Poly( ethylene glycol)dimethacrylate 
· PET 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 ° Polyethylene terephthalate 
PLGA 0 0 0. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 ° 0 0 0 ° 0 0 0 0 0 0 Poly(lactic-co-glycolic acid) 
PMA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Poly( methyl acrylate) 
PMMA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 Poly( methyl methacrylate) 
rpm 0 0 0 0 0 0. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Rounds per minutes, unit for rotation speed 
seem 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Standard cubic centimeters per minute, unit for gas flow rate 
sp6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Sulfur hexafluoride 
s. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Second, unit of time 
Si 0 0 0 0 0 0 0 0 0 0 0 0 0 00 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Silicon 
T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 T esla, unit for magnetic field strength 
t 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Thickness of the hollow-cylinder wall 
Tl 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Longitudinal relaxation time, or spin-lattice relaxation time 
T2 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Transverse relaxation time, or spin-spin relaxation time 
Ta 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0. 0 0 0 0 0 0 0 0 Tantalum 
TaOxo 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Tantalum oxide 
Ti 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Titanium 
XXX 
y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Gyromagnetic ratio 
y(H) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 Gyromagnetic ratio of hydrogen proton, 42
0
6 [MHz/Tesla] 
.0.roo 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 : 0 0 0 0 0 0 0 0 Frequency shift 
8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 . 0 0 0 0 0 0 0 Flip angel 
1-l o 0 0 0 0 0 0 0 0. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 • 0 0 0 Linear attenuation coefficient 
I-LL 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0: 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 0 , 0 0 0 0 0 Microliter, unit of volume 
j.lmo 0 0 0 0 0 0 . 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 Micrometer, unit oflength 
't 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 • Pulse duration 
roo 0 0 0 0 0 0 0 0. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 ° 0 0 0 0 0 0 0 0 0 0 0 0 Angular precessional frequency 
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CHAPTER! 
INTRODUCTION 
1.1 Overview 
The power of a biomedical imaging modality can be augmented and is, in large 
part, determined by the capabilities of the available contrast agents. For example, 
quantum dots represent a colorful palette of powerful contrast agents for optical 
fluorescence imaging and Raman spectroscopy, given their tunable multiplexing 
capability and long-term stability compared to traditional organic molecule-based 
fluorescent labels (Medintz, Uyeda, Goldman, & Mattoussi, 2005). As shown in Figure 
1-1 (Lin et al., 2007; Medintz et al., 2005), in vivo multiplexing fluorescence imaging of 
mouse embryonic stem cells (ESCs) labeled with six different quantum dots excited using 
a single light source serves to highlight some of the existing limitations of the currently 
available contrast agents in magnetic resonance imaging (MRI) and X -ray computed 
tomography (CT) (Lin et al., 2007). The multispectral nature of these modalities yields 
the capacity for the simultaneous imaging of myriad targets, allowing for the study of 
increasingly complex biological systems. 
In addition to the absence of multiplexing capability, MRI and CT contrast agents 
also lack the desired functional imaging or sensing capability (Nguyen et al., 201 0), as 
well as being limited by a generally low sensitivity (Black, 1994; Gary Zabow, Dodd, 
Moreland, & Koretsky, 2008). Moreover, conventional CT contrast agents also suffer 
from short vascular circulation time (Oh et al. , 2011), and lack specificity for any given 
1 
disease process (Schuknecht, 2007). 
r CdSe core (A) 
Amax em. (nm) 
(A) 
[Figure 1-1: (A) Size-tunable fluorescence properties and spectral range of six cadmium 
selenide (CdSe) quantum dot dispersions; (B) In vivo single light source excitation 
multiplexing fluorescence image acquisition of ESCs labeled with six different quantum 
dots, injected on the back of an athymic nude mouse.] 
This dissertation aims to mitigate the aforementioned limitations of the currently 
available contrast agents in MRI and CT by applying engineering methods, including top-
down fabrication techniques of micro- and nanoelectromechanical systems (MEMS and 
NEMS), in combination with bottom-up self-assembly and chemical synthesis 
approaches to precisely control the size, shape, as well as material properties of the 
contrast agent particles. to yield the next generation contrast agents for a wide range of 
biomedical imaging applications. An overview of this dissertation is shown in Figure 1-2: 
driven by two applications, MRI and CT, several new contrast agents will be designed, 
fabricated, and characterized to demonstrate the potential of applying engineering 
approaches towards the rational design of contrast agents, yielding strict control over 
several properties, including particle size and shape, among others. 
2 
Size and Shape Specific Contrast 
Agents for Biomedical Imaging 
MRI Contrast 
Scalable Nanomanufacturing Platform 
for Polymeric Nanorods 
[Figure 1-2: An overview of this dissertation.] 
To demonstrate the impact of shape and material properties on contrast agent 
design, two configurations of magnetic particles will be precisely fabricated as MR1 
contrast agents, to be carried out via the following specific aims: 
Aim 1.1 : Iron oxide material characterization. Material properties of iron oxide 
thin films deposited under different parameters will be characterized, including the 
chemical compositions, crystalline structures, magnetism, as· well as mechanical 
properties. 
Aim 1.2: Design and fabrication of micro- and nano-scale MR1 contrast agent 
particles. Two different configurations of magnetic particles, namely double-disk and 
3 
hollow-cylinder, will be fabricated usmg the material characterization knowledge 
acquired from aim 1.1. 
Aim 1.3: Validation of the MRJ properties of the fabricated particles. The 
multispectral capability of these geometrically controllable magnetic particles will be 
validated in vitro using MRJ. In turn, validation results will be used for the optimization 
ofaim 1.1 and 1.2. 
The' effects of particle aspect ratio and mechanical property, in addition to pariicle 
shape and material properties, will be further explored by developing a 
nanomanufacturing platform for polymeric nanorods potentially advantageous for CT 
imaging, to be carried out via the following specific aims: 
Aim 2.1: Proof-of-concept of the nanomufacturing platform at micro-scale. Using 
the combined imprint and photolithography technique with X-ray attenuating material as 
payloads to demonstrate the feasibility of the proposed method. 
Aim 2.2: Developing a combined imprint and photolithography hybrid mold at 
nano-scale. Anodized aluminum oxide (AAO) templates will be developed and employed 
to direct the pattern transfer of the nanoporous structure onto qua1iz substrates to achieve 
scalable nano-scale patterning. 
Aim 2.3: Both thermal and ultraviolet (UV) nanoimprinting using the hybrid mold 
developed in Aim 2.2 will be demonstrated to fabricate size and shape specific polymeric 
nanorods. 
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1.2 Dissertation Outline 
In Chapter 2, the background introduction will be given on medical imaging in 
general, with specific focus on CT and MRI, as well as the state of the art of the contrast 
agents currently available to these two imaging modalities. Several aspects for rationally 
design a contrast agent or drug delivery systems will be discussed, and methods currently 
available for engineering size and shape specific nanoparticles will be introduced. 
In Chapter 3, the design and fabrication of two configurations of MRI contrast 
agents will be presented, including double-disk and hollow-cylinder magnetic particles, 
as well as the material characterization results of biocompatible iron oxide thin films, and 
MRI validation experiment results. 
In Chapter 4, a novel nanomanufacturing platform for scalable fabrication of size 
and shape specific polymeric nanorods will be introduced and demonstrated at both 
micro-scale, for proof-of-concept, and at nano-scale, using self-assembled nanoporous 
AAO membranes. 
Conclusion and outlook of this dissetiation will be given in Chapter 5. 
Lastly, the colored version PDF file of this dissertation can be downloaded from: 
http://XiaoningWang.com/dissertation.pdf, or email the author directly to request a copy: 
contact@xiaoningwang.com. 
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CHAPTER2 
BACKGROUND 
Some background information pertinent to tlus dissertation will be introduced in 
tills chapter, including a brief overview of the history of medical imaging, with special 
focus on MRl and CT, as well as their working principles, followed by a review of the 
state-of-the-art of the contrast agents currently being used and developed for both clinical 
and research applications of MRl and CT. Finally, the advantages of using engineering 
approaches to rationally design and fabricate contrast agents will be discussed, and 
several current available approaches will be given as examples. 
2.1 Medical Imaging 
Before Rontgen's discovery of X-ray radiation in 1895 (Rontgen, 1898) (Figure 
2-1, the first X-ray image ever taken), which earned rum the very fust Nobel Prize in 
Physics in 190 1, the field of diagnostic medical imaging was practically nonexistent. The 
clinical investigative tools were then limited to the microscope, the thermometer, the 
knife and the stethoscope, wlllle the understanding of human body evolved from 
centuries of anatomical studies of the dead and functional observations of the living. 
Within a year of Dr. Rontgen' s announcement, X-ray radiography sets were made 
available, and the first X-ray guided operation was performed in England (Guy & ff)rtche, 
2005). With specialized development throughout the century, as well as discoveries of 
other imaging technologies, the ability to non-invasively visualize, examine, or measure 
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the hidden internal world of the living human body revolutionized the field of medicine. 
Up until the 1960' s, X-ray methods completely dominated the non-invasive medical 
diagnosis field, and are still considered to be the gold standard in areas such as 
mammography (for the early detection of breast cancer) and dentistry even today. 
[Figure 2-1: The very first X-ray picture taken by Dr. Wilhelm Comad Rontgen in 1895 
ofthe hand of his wife. (Medicine)] 
The first radical change happened to the medical use of X-rays in 1972, when Sir 
Godfrey Newbold Hounsfield (Figure 2-2) announced his invention of the first 
commercially viable computer-assisted X-ray tomographic scanner (Hounsfield, 1973), 
who later shared the 1979 Nobel Prize for Physiology or Medicine with Allan McLeod 
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Cormack (Cormack, 1963, 1964) for their independent effmis in developing the 
diagnostic technique ofX-ray computed tomography*. Supported by the wide adoption of 
digital computing facilities, CTt quickly became one of the most commonly used clinical 
diagnostic imaging tools given its obvious advantages over X-ray radiography, which 
make the interpretation of the resulting images much easier due to the following reasons: 
(1) CT completely eliminates the superimposition of the projections of the shadows of 
internal organs and bones outside the area of interest, and (2) CT provides much better 
contrast between different types of soft tissue, as well as between bones and all soft tissue 
(Guy & ffytche, 2005). It was estimated that nearly 72 million scans were performed in 
the United States in 2007 (Berrington de Gonzalez, Mahesh, Kim, & et al., 2009), as CT 
is routinely used for the rapid assessment of structural abnormalities throughout the body 
due to trauma or diseases (Brenner & Hall, 2007). However, regardless of the 
unprecedented popularity of CT in the medical field, the relatively large dose of ionizing 
radiation it entails with each scan still poses certain health concerns and possible side 
effects to patients, while the spatial and tissue resolution remains limited due to the small 
differences in X-ray contrast between different types of soft tissues (Brenner & Hall, 
2007; Guy & ffytche, 2005). 
* The word tomography is derived from Ancient Greek 'tOJ.lO~ tomos, "slice, section" and ypa<pco 
graph<), "to write". 
t There are many other types of computerized tomographic imaging teclmiques, such as MRI, 
positron emission tomography (PET), single-photon emission computed tomography (SPECT), 
etc. However, the term CT is most often used to refer to X-ray computed tomography, since it is 
the most common form ofCT techniques. 
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"Your Majesties, Your Royal Highnesses, Ladies and Gentlemen, 
Neither of this year's laureates in physiology or medicine 
is a medical dod or. Nevertheless, they have achieved a revolution 
in the field of medicine. It is sometimes said that this new X-ray 
method that they have developed- computerised tomography 
-has ushered medicine into the space age. 
Few medical achievements have received such immediate 
acceptance and met with such unreserved enthusiasm as 
computerised tomography. It literally swept the world~ 
[Figure 2-2: Sir G. N. Hounsfield with the first CT scanner prototype, the EMI CTlOOO, 
and an excerpt from the presentation speech by Professor Torgny Greitz at the Nobel 
prize ceremony in 1979. (Greitz, 1979; Telegraph, 2004)] 
Similar to CT, MRI * is also a tomographic imaging technique ·in that the 
computer generated images are reconstructed through a process that first reduces a 3D 
volume of interest by a series of slicing steps, then each of the 2D slices are analyzed in 
tum by acquiring a complete set of projections of that slice. By recombining these 
projections according to a particular mathematical algorithm, a 2D image can be 
reconstructed (Guy & ffytche, 2005). Through further manipulation of the whole 
volumetric data, a 3D representation can also be achieved by most modem scanners. 
However, unlike CT, MRI has no associated ionizing radiation hazard and can provide a 
wider range of contrast mechanisms and much better resolution in distinguishing between 
soft tissues. The fundamental principles of MRI originated from the research in nuclear 
magnetic resonance (NMR) during the late 1930's to 1940' s: Dr. Isidor Isaac Rabi was 
* Also known as nuclear magnetic resonance imaging (NMRJ), or magnetic resonance 
tomography (l\1RT). 
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awarded the Nobell>rize in Physics in 1944 "for his resonance method for recording the 
magnetic properties of atomic nuclei" (Nobelprize.org, 2013b), and Dr. Felix Bloch and 
Dr. Edwards Mills Purcell shared the Nobel Prize in Physics in 1952 "for their 
development of new methods for nuclear magnetic precision measurements and 
discoveries in connection therewith" (Nobelprize.org, 2013c). Dr. Richard R. Ernst was 
also awarded the Nobel Prize in Chemistry in 1991 "for his contributions to the 
development of the methodology of high resolution nuclear magnetic resonance (NMR) 
spectroscopy" (Nobelprize.org, 20 13a). 
[Figure 2-3: The first whole-body MRl scanner developed by FONAR Inc., and the first 
MRl scan of a live human chest.] 
Despite being widely used in physics, chemistry, biology and many industrial 
settings, the idea of utilizing spatially localized NMR signal for medical imaging was 
realized years later in 1973 by Dr. Paul Lauterbur (Lauterbur, 1973), who shared the 
Nobel Prize in Physiology or Medicine in 2003 with Sir Peter Mansfield "for their 
discoveries concerning magnetic resonance imaging" (Nobelprize.org, 2013d). Dr. 
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Raymond Damadian * published the first whole-body scan in 1977 (R. Damadian, 
Goldsmith, & Minkoff, 1977; R. V. Damadian, 2011 ), although the images were of very 
low quality due to the low field strength (0.1 Tesla) of the magnet, and the total 106 data 
points were acquired over a period of 4 hours and 45 minutes, as shown in Figure 2-3. 
Since then, however, with the significant reduction in scan time as well as new 
techniques and more powerful hardware, MRI is rapidly becoming the method of choice 
for an increasing number of clinical investigations given its radiation-free and oftentimes 
superior imaging quality. 
The basic working principles of both CT and MRI will be introduced herein. 
2.1.1 Computed Tomography 
As briefly mentioned already, a maJor limitation of conventional X-ray 
radiographs is that when projecting a 3D object onto a 2D plane, overlying tissues are 
being superimposed on top of one another, causing undesired difficulties in the 
interpretation of the image. Tomography techniques, such as CT and MRI, on the other 
hand, solved this problem by reducing a 3D volume first to a collection of 2D sections 
through a series of slicing steps, then each slice is cross-hatched with lines to produce a 
collection of 1D strips and this data can be recombined to form a cross-sectional image, 
or further reconstructed to a 3D representation. Depending on the different fields of 
applications of tomography, the data collection process and the source of image contrast 
* There have been some controversies regarding the 2003 Nobel Prize in Physiology or Medicine, 
as to whether Dr. Dam ad ian should also be sharing the award (Kenneth Chang, 2004 ). 
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may vary from one technology to another based on their specific physics and engineering 
principles. However, essentially the same mathematical algorithm is used to create the 
final image after the raw data has been collected (Guy & ffytche, 2005). 
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[Figure 2-4: A simple illustration of the tomographic technique.] 
Another simple way to understand the tomographic principle is illustrated in 
Figure 2-4 (Littleton & Littleton, 1996). The X-ray source moves from position T 1 to T 2, 
while the X-ray detector (film) moves in the opposite direction from position F1 to F2 . All 
the points in the section plane during the exposure will be projected at the same location 
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on the film (AI and A2), resulting in sharp focus, whereas all the points outside of the 
section plane will be projected at different locations on the film (BI and B2), resulting in 
blurred or effaced points on the final image. By moving the point of rotation (fulcrum) 
between the X-ray source and detector, or moving the object, the section plane can be 
changed, therefore the whole slice can be imaged. This early "crude" tomographic 
technique already existed in the 1950's without the aid of a computer (Pollak, 1953). 
Translate 
1-2-3 
X-ray Detector 
~~ 
I X-ray Source 
fV 
I 
[Figure 2-5: The first generation X-ray CT scheme by Hounsfield.] 
X-ray CT harnesses the processing power of the computers to drastically reduce 
the amount of time to collect and analyze the tomographic data. The first generation CT 
scanner scheme "Translate-Rotate" is shown in Figure 2-5 (Guy & ffytche, 2005), where 
a collimated single fine pencil X-ray beam was scanned across the patient into a single 
electronic X-ray detector to record the relative absorption at each point within a single 
projection, i.e. the translate phase. Next, in the rotate phase, the direction of the X-ray 
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beam is altered to acquire subsequent projections necessary for image reconstruction 
using the backprojection algorithm (Guy & ftytche, 2005), which is a form of Radon 
Transformation applied in image processing (Radon, 1986). The relative absorption of 
the X-ray beam is determined by the X-ray strength (photon energy, expressed in 
electronvolt [ e V], or kilo-electronvolt [ke V]), and the characteristics of the structure in its 
path, including density, thickness and atomic number of the material, as shown in Figure 
2-6 (Romans, 2011). The average X-ray energy is determined by the maximum voltage 
applied across the X-ray tube (peak kilovoltage [kVp]), whereas the scan dosage (amount 
of X-ray photons) is determined by the product of X-ray tube current (milliampere [rnA]) 
and the scan time [s] , i.e. milliampere-second [mAs]. The degree to which an X-ray beam 
is reduced by an object is referred to as attenuation, expressed as shades of gray on the 
final image where the brightest pixel represents the highest attenuation, and the darkest 
the lowest attenuation, with various intermediate attenuation capacity in between as 
shades of gray (Romans, 2011). 
(B) 
[Figure 2-6: (A) The object in the path of the X-ray is thicker, denser, and composed of 
heavier atoms than that of the object depicted in (B), meaning that (A) has a higher X-ray 
attenuation than (B).] 
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In modern CT scanners, each slice is comprised of a 512 x 512 array of pixels. If 
the thickness of the slice is considered, each pixel represents a voxel in the object, and its 
X-ray attenuating property is quantified by aCT number, expressed in Hounsfield Units 
(HU) ranging from -1000 HU to 4000 HU, defined as such: 
CT Number [ HU] = fl voxel - flwater X 1000 
Jlwater -flair 
Eq. 2-1 
where 11 is the linear attenuation coefficient. By this definition, the CT number of water is 
0 HU, and air is -1000 HU. The linear attenuation coefficient and the corresponding CT 
number in HU of some common biological substances are listed in Table 2-1 (Bushong, 
2013). A difference in density between adjacent objects is necessary in order to 
differentiate one from the other, therefore radiopaque contrast materials are often 
administered orally or intravenously to fill the area of interest and create a temporary 
artificial density difference between objects (Romans, 2011). However, it is worth noting 
that based on the linear attenuation coefficient data, X-rays are particularly good at 
differentiating bones from soft tissue, but rather poor at distinguishing different types of 
soft tissue. Due to the high dynamic range of HU values, "windowing" is oftentimes 
necessary so that more information can be discerned on an 8-bit (256 levels) gray scale 
Image. 
Table 2-1: Linear attenuation coefficient at 125 kVp and corresponding HU values for 
some common biological substances 
Substance 
Air 
Lung 
I 0.0003 I -1000 
-·- t __ · ~?.mii.-r ... ~20-0 .. -
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[Figure 2-7: The fourth generation CT scanner with a ring of fixed X -ray detectors, and a 
fan shaped beams ofX-rays from a rotating source.] 
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Modern CT scanners are much more advanced in terms of both hardware and 
software. As illustrated in Figure 2-7 (Bushong, 2013), fan shaped beams are produced 
from a rotating X-ray tube and the projection data are collected on a 360° ring of fixed 
detector anay. In addition to this "rotate-only" design, innovations in image 
reconstruction algorithms have also helped to significantly reduce the amount of time 
needed to acquire the data and generate the image, as well as to minimize the patient' s 
exposure to X-rays. Compared to the 5 minutes required to obtain just one slice of data 
for the first generation scanners, cunent technology requires less than a second. 
For more details on the development of X-ray CT technology, and the data 
acquisition and image reconstruction process, refer to the text books: "Radiologic 
Science for Technologists: Physics, Biology, dnd Protection " by Dr. Bushong (Bushong, 
2013), and "Computed Tomography for Technologists: A Comprehensive Text " by Dr. 
Romans (Romans, 2011 ). 
2.1.2 Magnetic Resonance Imaging 
Magnetic resonance imaging, or MRI, is an advanced medical imaging technique 
used in radiology for visualizing detailed internal structures with enhanced soft tissue 
contrast and non-ionizing radiation compared to other medical imaging techniques such 
as CT or X-rays, which makes it an especially powerful tool for brain, muscle, abdominal 
and a range of cancer diagnostics. Figure 2-8 shows an illustration of the MRI scanner, 
and an example MR image (Coyne). 
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(A) MRI Scanner Cutaway 
[Figure 2-8: (A) A cutaway view of a generic MRI scanner. (B) An example MRI scan 
of part of the human vertebrae in the sagittal plane, highlighting a hemiated disc.] 
The human body is largely composed of water molecules, each of which consists 
of two hydrogen nuclei or protons. When performing MR imaging, an extemal magnetic 
field Bo is applied through the main magnet ("Magnet" in Figure 2-8 A), causing the 
magnetic dipole moment (MDM) of those hydrogen protons' spins to align with the 
direction of the extemal field. Bois typically on the order of 1.5 or 3.0 Tesla* [T] in most 
clinical settings but can reach as high as 22 T for research purposes. Once the proton is 
placed in a large magnetic field, it begins to "wobble" or precess, which means it not only 
spins about its own axis, but also rotates about the axis of the extemal magnetic field Bo 
(Figure 2-9 A). The rate at which the proton precesses around the Bo axis is given by 
Larmor equation: 
* The units used in magnetism can be confusing sometimes due to different unit systems (CGS or 
SI) are being used simultaneously, 1 T = 104 Gauss [G] = 104 Oersted [Oe]. For more information 
on unit conversion, refer to Appendix A: Conversion of Units. 
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Eq. 2-2 
where wo is the angular precessional frequency of proton, and y is the gyro magnetic ratio, 
which for hydrogen protons, y(H)=42.6 [MHz/Tesla] (Hashemi, Bradley, & Lisanti, 
2004). 
(A) (B) B0=const 
y 
(C) 
X 
Mz 
(T1) 
y 
[Figure 2-9: Illustrations of the MRI working principle: (A) proton self-spin generates a 
magnetic dipole moment, and precessing around the direction of the external magnetic 
field. (B) RF magnetic field E 1 "flips" the self-spin axis from the Z direction into the X-Y 
plane. (C) Longitudinal relaxation time Tl and transverse relaxation time T2.] 
In order to transmit and receive signals from the patient (or biological samples) 
inside the MRI scanner, a radio frequency (RF) pulse is transmitted through the RF coil 
(see Figure 2-8 A) perpendicular to Eo (z axis in Figure 2-9 B) and generates another 
alternating magnetic field E 1· Compared to the stronger constant external field Eo, this is 
a much weaker magnetic field oscillating at frequency wo, which will match the Larmor 
precessional frequency of the proton and yield precession about the x axis at another 
frequency w 1 determined again by Larmor equation: 
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Eq. 2-3 
The "flip angle" e of the magnetization vector of the proton from Z axis towards 
the X-Y plane is determined by the strength of RF pulse B 1 and its duration r: 
Eq. 2-4 
After the RF pulse is turned off, the proton spins begin to relax back to their 
lowest energy state or the equilibrium state, and realign with the axis of Bo. The excess 
energy from this process is released and can be received by the same coil that transmitted 
the RF pulse. The rate at which Mz (longitudinal magnetization vector) recovers to the 
original magnetization Mo is denoted by Tl, called the longitudinal relaxation time or 
spin-lattice relaxation time. As the longitudinal magnetization vector Mz recovers, the 
transverse magnetization vector A{,yydecays more rapidly (5 to 10 times faster than Tl) at 
a rate characterized by T2, called the transverse relaxation time or spin-spin relaxation 
time (see Figure 2-9 C). The reason why Tl and T2 are occurring at the same time but at 
two different rates is because as B 1 is turned off, proton spins start to become out of 
phase with each other at a much faster speed than their relaxation back to their original 
state. The two components: Mz and MXY, are characterized by these two exponential 
growth/decay functions: 
Eq. 2-5 
M (t)- M e-Yr2 XY - 0 Eq. 2-6 
As opposed to the ideal case described above, however, what is actually 
happening after B 1 is turned off is also affected by the inhomogeneities of the external 
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magnetic field Bo, which causing A{rr decays at a slightly faster rate T2 *: 
Eq. 2-7 
Different tissues have different proton spin densities, denoted by N(H) , which 
determine the net magnetization vector Mo. Therefore the signals from different tissues 
received by the RF coil are also different. Additional tissue contrast concepts and image 
reconstruction processes are beyond the scope of this dissertation. However, related 
material and a more detailed explanation on MRI working principles can be found in the 
book "MRI: The Basics" authored by Dr. Hashemi (Hashemi et al. , 2004). 
2.2 Contrast Agents 
Following the early development of X-ray radiography, as the X-ray beams 
became more powerful, radiologists began giving patients radio-opaque barium (Ba) 
orally or as an enema and taking films as the barium traversed the gastrointestinal (GI) 
tract in the 1920' s. This procedure was named fluoroscopy, which was a method by 
which cancers and other lesions in the GI tract (esophagus, stomach, bowel, etc.) were 
initially diagnosed (Bradley, 2008), and was considered one of the first uses of contrast 
enhancing material in medical imaging. 
By definition, contrast agents, or contrast medium, refer to the type of substances 
used to enhance the contrast of structures or fluids within the body in medical imaging 
for aid in visualization (Dorland & Newman, 2012). Depending on the imaging modality, 
they can be categorized into three types: X-ray attenuating radiocontrast agents, MR 
signal enhancing MRl contrast .agent, and sound wave scattering microbubbles for 
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contrast enhanced ultrasound imaging. By their contrast enhancing behavior, they can 
also be generally categorized as: "positive" agents that increase the image intensity 
locally, and "negative" agents that decrease the image intensity locally. Note that the 
contrast enhancement discussed herein does not refer to the use of digital image 
processing algorithms, such as edge detection method, to achieve the change in local 
image intensity so that different structmes or tissue types can be differentiated from one 
another (Guy & ffytche, 2005). Rather, it is achieved by a change in the measmement 
procedme, such as by inducing a difference in radiopacity between adjacent structmes 
(for CT), or changing the proton spin .properties locally to affect their relaxation times 
(for MRI). 
MRI and CT contrast agents will be discussed below, with the main focus being 
on their limitations. 
2.2.1 Current MRI Contrast Agents 
As briefly mentioned in the Overview section in Chapter 1, the current generation 
of MRI contrast agents are mainly limited by a lack of multiplexed imaging, relatively 
low sensitivity, as well as a lack of functional imaging or sensing capability. Categorized 
by their effect on the image, "positive" contrast agents (Geraldes & Lament, 2009), such 
as gadolinium chelates, shorten T1 relaxation times and "brighten" the local 
environments affected by these agents (Hendrick & Mark Haacke, 1993), whereas 
"negative" contrast agents, such as (ultrasmall) superparamagnetic iron oxides (USPIO, 
SPIO), function largely by shmiening T2 relaxation times and "darken" the image 
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(Weissleder et al. , 1990). These monochromatic responses in black and white, as 
represented in Figure 2-10 (McAteer et al. , 2007), are in sharp contrast to the rich, multi-
colored palette available with optical imaging contrast agents already demonstrated in 
Figure 1-1 . 
[Figure 2-10: Imaging inflammation with MR1 in a mouse model of multiple sclerosis 
using an iron oxide agent. (A, B) Iron oxide retention in inflammation demonstrates a 
monochromatic response as punctuate low intensity foci throughout the brain. (C, D) 
. Control group mouse brains without contrast agent injection. (Scale bar: 5 mm)] 
Several recent efforts have been focused on mitigat~ng the lack of multiplexing 
capability of MR1 contrast agents. These include using chemical exchange saturation 
transfer (CEST/PARACEST) techniques wherein multiple exogenously or endogenously 
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administered compounds containing either exchangeable protons or molecules are 
selectively saturated and transferred, after which they are indirectly detected through the 
free water pool (van Zijl, Jones, Ren, Malloy, & Sherry, 2007). The diverse spectral 
frequencies afford the potential for multiplexing using MRI (Snoussi, Bulte, Gueron, & 
van Zijl, 2003 ; Wu, Zhao, Kiefer, & Sherry, 2010). Alternatively, Zabow et al. 
demonstrated a paradigm shifting top-down fabrication approach to develop precisely 
microengineered nickel/copper structures with tunable, multi-spectral properties (Gary 
Zabow et al. , 2008; G. Zabow & et al., 2009; Gary Zabow, Koretsky, & Moreland, 2009). 
Unlike the amorphous spherical shaped iron oxide nanoparticles, their top-down 
approach yields precise geometric structures. While not optimally biocompatible based 
on their materials used for fabrication (Permenter, Lewis, & Jackson, 2011), Zabow et al. 
have developed precisely manufactured magnetic double disk or cylindrical structures 
which alter the local magnetic field in a distinct, homogeneous, and predictable fashion. 
These distinct field alterations yield a unique spectral resonance frequency of the 
fabricated particles which is tunable based on the specific geometric properties of the 
individual particles as well as the magnetic properties of the material employed in 
microfabrication, as shown in Figure 2-11 (Gary Zabow et al., 2008). These recently 
demonstrated fabricated magnetic structures with resolvable, distinct, and tunable 
spectral signatures allow for the potential of true multiplexing capacity using MRI. 
24 
(A) 
. -
. . 
• 
• • 5mm 
• I -
. -
- -
.. 
.. . . 
• • . . 
• 
. . 
. 
• I 
- . 
. ' . 
. . 
I • • - • 
• l - . 
(C) 
(D) --65kHz 
__iLl_... ......_.____ 
~~--6-8-k_H_z----~ 
r;-'-44 kHz 
I ~A)~\ 
R 811H JJ{\ ' 
Frequency shift 
[Figure 2-11: Chemical shift imaging (CSI) of demonstration 1.25 mm diameter patiicles 
magnetized by Bo. (A) Spatial imaging using gradient-echo MRI similar to SPIO 
detection. (B) Chemical shift images show additional spectral information can 
differentiate particles with different geometries as shown (not-to-scale) in (C). (D) 
Patiicle spectral shift off water proton line with respect to their geometry differences.] 
In addition to the lack of multiplexed imaging, a second drawback to current MRI 
contrast agents is their relatively limited sensitivity, which hinders the development of 
targeted molecular MR imaging applications, such as localizing a particular tumor 
antigen or targeted imaging of a particular component of an atherosclerotic plaque, due to 
the exceedingly large concentrations of contrast agents necessary to localize to a specific 
site to yield perceivable contrast enhancement (Sosnovik & Weissleder, 2007). The open 
design of the top-down fabricated contrast agent particles introduced by Zabow et al. 
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serves to amplify the pmiicles' signal via diffusion driven signal amplification. Both the 
double-disk and hollow-cylinder structmes allow for the diffusion of water through the 
distinct magnetic fields created within the fabricated particles. By repeatedly directing 
satmation pulses to the resonant frequency of the hydrogen protons within the particles, 
the satmated protons rapidly exchange with the surrounding free pool water through 
Brownian motion, exponentially increasing the total volume of satmated water, thereby 
amplify the generated signal per pmiicle. This diffusion driven enhancement of signal is 
increased by up to fom orders of magnitude when compared to similarly sized magnetic 
particles without diffusion related signal enhancement (Gm·y Zabow et al. , 2008). 
[Figure 2-12: Apoptosis imaging · using a caspase activatable fluorescent peptide. 
Apoptotic (A) and control (B) HeLa cells demonstrate marked sensitivity of the peptide 
to caspase activity.] 
A final notable limitation of the current generation of MRl contrast agents is the 
lack of functional imaging capability. Currently, the local image darkening or brightening 
in response to the presence of an MRl contrast agent offers little more than location 
information, while a true sensing capacity in response to the local biological environment, 
such as currently available with optical imaging agents, is missing. For instance, optical 
26 
agents with enzyme cleaved complexes which yield signal in the presence of particular 
enzymes, such as those associated with cancer or inflammation, highlight the existing 
limitations of MRI contrast agents (Kiyuk Chang et al., 2010; Maxwell, Chang, Zhang, 
Barnett, & Piwnica-Worms, 2009) (Figure 2-12). 
2.2.2 Current CT Contrast Agents 
CT has come to represent one of the most common clinical imaging modalities to 
date since its introduction in the early 1970's (Beckmann, 2006). The currently available 
commercial CT contrast agents, typically in the form of water soluble organic iodinated 
compounds (Schuknecht, 2007), are, however, limited by short vascular circulation times, 
low sensitivity at clinically relevant CT X-ray energy levels, a lack of specificity for any 
given disease process, as well as a lack of functional imaging or sensing capacity. 
Hindered by these constraints, the true potential of CT as a biomedical imaging modality 
remains largely unrealized. 
The short blood circulation times of the iodinated CT contrast agents secondary to 
rapid renal excretion limits many applications of these agents, including CT angiography 
or target-specific imaging applications. Recently, several approaches to mitigating the 
rapid vascular circulation time have been demonstrated using nanoparticulate contrast 
agents (Ho Kong et al. , 2007; D. Kim, Park, Lee, Jeong, & Jon, 2007). Specifically, by 
increasing the size of contrast agent, as well as using a PEGylated nanoparticle surface, 
tl1e circulation times can be improved from several minutes to hours (Figure 2-13) (Ho 
Kong et al., 2007). Additionally, several novel approaches which take advantage of 
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particle shape and elasticity have yielded interesting insights into the possibility of 
dramatically increasing contrast agent circulation times. It has been demonstrated that 
filament-shaped particles of up to nearly 20 ).!ill in length achieve circulation times of up 
to one week, possibly due to the hydrodynamic forces on the filament-shaped particles 
which overcome typical cellular filtration and clearance systems (Geng et al. , 2007). 
Merkel et al. utilized a top-down, soft lithography (particle replication in non-wetting 
templates, PRINT) approach to fabricate biconcave discoidal shaped particles simulating 
the size, shape and elasticity of mature red blood cells, which yielded vascular circulation 
times on the order of several days (Merkel eta!., 2011 ). 
[Figure 2-13: Intravenously administered lipiodol-loaded Pluronic/PEG nanocapsules 
shown to enhance vascular contrast for up to 4 hours.] 
Another inherent limitation with the use of iodinated contrast agents in their 
conventional form is their suboptimal X-ray attenuation at typical CT imaging energy 
levels*. This attenuation, determined by the atomic number and electron density of a 
given material, results in a limited sensitivity with the use of iodinated compounds in 
their current form at clinically acceptable dosages given their negative effects, notably, 
• A typical range is from 100 kVp to 140 kVp, most common X-ray energy level in clinical CT is 
120 kVp . 
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nephrotoxicity. As shown in Figure 2-14, gold (Au) has demonstrated superior X-ray 
attenuation throughout the energy spectrum, whereas iodine only has comparable contrast 
enhancement at lower energy level and high dosage (Cormode et al., 2010). To date, 
various nanopatticulate formulations of Au and bismuth (III) sulfide (BhS3) have been 
employed as X-ray contrast agents (Boote et al., 2010; Kattumuri et al., 2007; Rabin, 
Manuel Perez, Grimm, Wojtkiewicz, & Weissleder, 2006), however, the high cost of Au 
and toxicity of Bi prevent their widespread clinical acceptance. Recently, tantalum (Ta) 
has attracted attention as a possible alternative material given its bioinertness, relatively 
low cost, as well as similar attenuation coefficient compared to Au and BizS3 (Black, 
1994). Several reported approaches to synthesizing tantalum oxide (TaOx) nanoparticles 
have demonstrated apparent biocompatibility and excellent X-ray attenuation properties 
(Bonitatibus et al., 2012; Oh et al., 2011). 
25-34 keV 
34-51 keV 
51-80 keV 
80-91 keV 
91-110keV 
110-130 keV 
Au-HDL Iodine 
• • •• 
[Figure 2-14: CT images of phantom containing various concentrations (0, 20, 30, 50, 
100 mM concentration, from left to right) of gold high-density lipoprotein nanoparticle 
(Au-HDL) and iodinated contrast agent at different CT energy levels.] 
Increasing the specificity of CT contrast agents to certain disease processes offers 
the potential to further increase the diagnostic capability of this imaging modality; for 
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example, using contrast agents designed to specifically accumulate in or bind to tumors 
with limited accumulation in nearby normal tissues, cancer detection sensitivity can be 
significantly improved. By simply taking advantage of the enhanced permeability and 
retention (EPR) effect of leaky tumor vasculatures using appropriately sized, larger 
particles as well as additional surface targeting moieti~s, passive tumor targeting can be 
achieved (Figure 2-15) (Dufort, Sancey, Wenl<, Josserand, & Coll, 2010; R. K. Jain, 
2005 ; Matsumura & Maeda, 1986; Popovtzer et al. , 2008). In addition to increasing the 
size, particle shape and surface modification are also gaining recognition as critical 
factors in modulating biodistribution as well as tumoral accumulation (Decuzzi et al. , 
201 0). For example, by taking advantage of the reticuloendothelial system (RES), or 
mononuclear phagocyte system (MPS), where particles of certain size and surface 
chemistry tend to accumulate much more easily in certain organs of the immune system, 
another fmm of passive targeting mechanism becomes possible (A. Z. Wang, Langer, & 
Farokhzad, 2012). 
(A) Normal Abnormal 
[Figure 2-15: (A) Organized, hierarchical vasculature in normal tissues, versus aberrant 
angiogenic vasculature present in solid tumors. (B) Passive targeting of subcutaneous 
tumor by fluorescent nanoparticles via EPR effect.] 
Last but not least, similar to the limitations of conventional MRI contrast agents, 
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current CT contrast agents are largely limited by the lack of multiplexing capability, as 
well as functional imaging capacity, in which the agents can act as sensors in response to 
the local biological environment. Other than localization information through image 
brightening, iodinated CT contrast agents lack a true sensing capacity which is starkly 
contrasted by the myriad optical imaging agents discussed above (Kiyuk Chang et al. , 
2010; Lin et al. , 2007; Maxwell et al. , 2009; Medintz et al. , 2005). 
Other CT contrast agents less frequently used include: barium sulfate, air, water, 
and carbon dioxide (C02) etc. 
2.3 Engineered Micro/N anoparticles 
To mitigate the aforementioned limitations of current MRI and CT contrast agents, 
this disse1iation focuses on utilizing mainly top-down engineering techniques, in 
combination with bottom-up self-assembly and chemical synthesis approaches, to achieve 
new classes of contrast agents with precisely controllable size, shape, and material 
properties. More specifically, using both MRI and CT as example imaging modalities, 
this dissertation seeks to study the impact of these properties on the potential diagnostic 
utility of the contrast agents . 
The concept of "Nanomedicine" originated from the famous talk by Richard P. 
Feynman * in 1959, "There 's Plenty of Room 'at the Bottom ", where he described what is 
* Shared The Nobel Prize in Physics in 1965 with Julian Schwinger and Sin-Itiro Tomonaga, 
"for their fundamental work in quantum electrodynamics, with deep-ploughing consequences for 
the physics of elementary particles" . (Nobelprize.org, 2014) 
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now known as the "top-down" fashioned nanotechnology: machines are used to make 
smaller machines, which in turn to be used to make even smaller machines, and so on so 
forth all the way down to the atomic level. The medical applications of nanotechnology, 
namely nanomedicine, were also envisioned by Dr. Feynman and included these tiny 
robots and machineries could be designed, manufactured, and introduced into the human 
body to perform repairs at the cellular and molecular level (Feynman, 1960): 
"A ji-iend of mine (Albert R. Hibbs) suggests a very interesting possibility 
for relatively small machines. He says that, although it is a very wild idea, 
it would be interesting in surgery if you could swallow the surgeon. You 
put the mechanical surgeon inside the blood vessel and it goes into the 
heart and looks around. (Of course the information has to be fed out.) It 
finds out which valve is the faulty one and takes a little knife and slices it 
out. Other small machines might be permanently incorporated in the body 
to assist some inadequately functioning organ. " 
The actual use of micro/nanotechnology, specifically micro/nanoparticles, in 
biomedical applications, is a relatively new trend starting to gain increasing attention in 
the past two decades (Freitas Jr, 2005; "Nanomedicine: A matter of rhetoric?," 2006). 
Most research and development has employed spherically shaped micro/nanoparticles, 
owing to the fact that they can be synthesized in a bottom-up fashion in a relatively 
straightforward manner, including emulsion, dispersion, suspension polymerizations, 
precipitation and spraying techniques (Canelas, Herlihy, & DeSimone, 2009). Therefore, 
extensive studies have been done on spherical particles, regarding the roles that particle 
size and composition play in biodistribution (Sun et al. , 2005), cellular binding (Cmiez et 
al., 2007) and uptake (Y. Hu, Xie, Tong, & Wang, 2007; Yin Win & Feng, 2005 ; Zatmer, 
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Farrow, & Haines, 2001 ), as well as tumoral accumulation (Dreher et al., 2006; Goodman, 
Olive, & Pun, 2007), etc. However, when considering non-spherical particles, the 
combined effects of particle size, shape, and other properties on the aforementioned 
interactions between particles and biological systems have not yet been fully understood. 
One major limitation is that size and shape specific nanoparticles are much more difficult 
to fabricate on a scale that is economically viable. 
Since micro-scale particles are relatively limited from most of the in vivo 
applications (more on this in 3.5.2), in addition, their design and manufacturing are much 
more mature and less complicated then their nano-scale counterparts, the discussion in 
this section will mainly focus on nano-scale particles. In order to be more comprehensive, 
the scope of the discussion herein will also include therapeutic applications of 
nanoparticles, instead of just limiting on contrast agents. 
2.3 .1 Rational Design of Contrast Agents 
Nanoparticles in general can be made by either bottom-up or top-down techniques. 
Bottom-up approaches involve self-assembly of molecules and atoms to create 
nanoparticles, such as liposomes, micelles, and polymersomes formed from amphiphilic 
molecules through self-assembly (Discher & Ahmed, 2006; Immordino, Dosio, & Cartel, 
2006). The nature of such processes determines that these particles are spherically shaped 
and usually have relatively large size distributions (J. Wang, Byrne, Napier, & DeSimone, 
2011). Top-down fabrication techniques, on the other hand, can produce size and shape 
specific particles, which offer several key advantages in the development of novel 
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diagnostic and therapeutic agents that have resulted in an ongoing and increasing interest 
to realizing the full potential of nanomedicine (Davis, Chen, & Shin, 2008; Davis et al. , 
2010; Hrkach et al., 2012). 
To rationally design nanomedicines in order to achieve prolonged vascular 
circulation, targeted delivery, as well as functional capacities, the following design 
parameters are generally considered: 
A. Particle size 
It is well known that particle size plays a significant role in the biodistribution and 
cell intemalization processes. While nanoparticles smaller than 6 nm in size are readily 
cleared by the kidneys, larger particles evade renal clearance; however, particles in 
excess of 200 nm may be more readily cleared by the liver and spleen (Gratton et al., 
2007; Soo Choi et al., 2007). Optimal particle size is likely to be dictated by the specific 
clinical applications. For example, in the case of targeted cancer therapy, particles with 
diameters in the range of 30-200 nm preferentially accumulate (a form of passive 
targeting mechanism) in the tumor secondary to the EPR effect (Figure 2-15 A) while 
particles along the smaller end of this size range may subsequently penetrate the tumor to 
a greater degree (R. K. Jain & Stylianopoulos, 2010). This is due to the size of the 
particles that is smaller than the fenestrations in the aberrant angiogenic tumor 
vasculature, and the pat1icles could more readily gain access to the solid tumor and have 
higher retention times than in adjacent normal tissues, thus improving tumor specificity 
(Heneweer, Holland, Divilov, Carlin, & Lewis, 2011). The EPR effect, in the example of 
chemotherapeutics, yields a more favorable biodistribution which equates to higher 
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intratumoral and lower normal tissue drug concentrations. Ultimately, this may translate 
into lower drug toxicity and higher therapeutic efficacy for nanoparticle therapeutics. 
In addition to the EPR effect, in cases of inflammatory disease, passive targeting 
to the immune-related cells may be readily achieved based on particle size (Pinto-
Alphandary et al., 1994). For a given geometry, the particle size also affects the degree of 
intracellular trafficking, and particles in the sub-1 00 run size range have been fmmd to 
maximize the degree of intracellular localization in vitro (Albanese, Tang, & Chan, 2012; 
Chithrani, Ghazani, & Chan, 2006) (Figure 2-16). 
100nm 
[Figure 2-16: Transmission electron microscopy (TEM) images of gold nanoparticles 
with sizes (A) 50 run, (B) 74 run, and (C) 100 run trapped inside vesicles of a HeLa cell, 
respectively.] 
B. Particle shape 
As regards particle shape, a marked effect on cellular uptake rate has been 
demonstrated in relation to particle shape. In vitro, cellular internalization in non-
phagocytic cells has been reported to be optimized with rod shaped particles which 
exhibited a fourfold increase in cellular internalization rate compared to symmetrically 
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shaped pmticles (Gratton et al., 2007). Another dramatic example reports micro-scale 
spherical pmticles which are found to be cleared immediately from the first pass through 
the microvasculature while filament-shaped particles of up to nearly 20 )liD in length 
achieve circulation times of up to one week. This shape-based increase in circulation time 
is secondary to the hydrodynamic forces on the filament-shaped particles which 
overcome typical cellular filtration and clearance systems (Geng et al., 2007). In addition 
to the capacity to improve cellular internalization and vascular circulation times, rod or 
filament shaped particles have been fotmd to improve tmnor localization and mitigate 
against tumor escape, maximizing the tolerated dose of a chemotherapeutic in a 
preclinical model of cancer, resulting in improved drug efficacy. When compared to 
sphere shaped nanoparticles, nanorods have been shown to exhibit superior transpmt in 
porous media in vitro, an effect which resulted in a significantly greater tumor 
penetration, a critical factor in therapeutic efficacy (Chauhan et al. , 2011) (Figure 2-17). 
[Figure 2-17: Dramatic increase in tumoral transport and distribution of nanorods (B) 
compared to nano spheres (A). Vessels are shown in black, and nanoparticles are shown 
in green. Scale bar: 100 )liD.] 
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Decuzzi et al. also laid out the theoretical foundation that could guide the optimal 
design of size and shape specific nanopatiicles useful for the intravascular delivery of 
therapeutic and contrast agents (Decuzzi & Ferrari, 2006). It is also worth noting that 
contradictory results have been reported in the studies of the impact of patiicle shape and 
cellular interactions. Wang et al. concluded that this may be due to the early stage of the 
field and, therefore, a more robust and thorough system still needs to be explored (J. 
Wang et al. , 2011). 
C. Mechanical property 
Beyond particle size and shape, mechanical properties have been demonstrated to 
influence particle behavior in biological systems as well. The mechanical properties of 
particles, in addition to size and shape, have recently been shown to dramatically 
influence the vascular circulation time of a non-spherical particle fabricated using imprint 
lithography. Using a soft lithography (particle replication in non-wetting templates, 
PRJNT) approach, biconcave discoidal shaped particles simulating the size, shape and 
elasticity of mature red blood cells yielded vascular circulation times on the order of 
several days (Merkel eta!., 2011 ). While rigid, discoidal particles on the order of 6 !-LID in 
diameter were found to be readily entrapped in various organs such as the lung, 
decreasing the modulus of the particles by altering the crosslinking of the hydrogels 
composing the microparticles was shown to yield significant increases in circulation time. 
The mechanical properties of patiicles have also been demonstrated to influence both the 
mechanism and kinetics of cellular uptake. Interestingly, the cellular uptake mechanism 
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between soft and hard nanoparticles is reported to differ. Importantly, nanoparticles 
exhibiting an intermediate elasticity were internalized via multiple mechanisms, resulting 
in an overall increased cellular uptake rate (Banquy et al. , 2009). 
CT PET PET/CT 
[Figure 2-18: Highly specific twnor targeting of antibody-labeled nanographene imaging 
agents (yellow arrow).] 
D. Surface property 
In addition to the enhanced specificity afforded by the effects of passive targeting, 
nanoparticle surface modifications enable enhanced target localization and cell 
internalization for myriad biomedical applications (Kirpotin et al. , 2006; Park et al. , 
2002). In applications to twnor therapy, surface modifications include an exploitation of 
the overexpression of surface receptors on cancer cells, using specific targeting ligands to 
decorate the nanoparticle surface, yielding improved localization to the twnor (C. H. J. 
Choi, Alabi, Webster, & Davis, 2010). Targeting ligands which have been successfully 
employed to improve nanoparticle localization to a target area of interest include 
monoclonal antibodies, aptamers, peptides, antibody fragments , and small molecules 
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(Figure 2-18) (Hong et al., 2012). In addition, other surface modifications for improving 
targeting specificity yield the capacity for "stealth" coatings to avoid unintended 
macrophage uptake and systemic clearance as well as control over nanopatiicle charge, 
known to influence cellular uptake and intracellular trafficking (C.-M. J. Hu et al. , 2011 ; 
Yue eta!. , 2011). 
2.3.2 Cunent Fabrication Techniques 
Given the key advantages of nanoparticles in therapeutic and diagnostic agent 
delivery outlined above, myriad approaches have been employed to yield nanoparticle 
formulations which typically include a nanocanier housing the agents of interest. Various 
approaches to optimizing these nanocarriers have been developed including liposomes, 
micelles, metallic nanoparticles, dendrimers, and polymer particles, among many others 
(Kaiser et al., 2013; Moon et al., 2011; Pan-ott et al., 2012; Xu, Feng, Li, & Gao, 2012; 
Yuan, Fu, Kao, Janigro, & Yang, 2011). In contradistinction to the typical bottom-up 
approach to nanoparticle synthesis, relying mainly on self-assembly methods, a paradigm 
shifting approach to drug delivery science employs a top-down engineering approach to 
the design and fabrication of next generation nanoparticle agents (Figure 2-19) (Enlow, 
Luft, Napier, & DeSimone, 2011). Top-down approaches to nanoparticle fabrication 
enable strict control over particle size and shape, both of which are being increasingly 
realized to be powerful features in optimizing nanoparticle agents, as well as other 
properties as described in the previous section. Also, drug loading efficiency has been 
shown to be improved with top-down approaches to nanoparticle fabrication, yielding 
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improvements in both fabrication efficiency as well as therapeutic efficacy (Acharya et 
al. , 2010; Enlow et al., 2011). 
[Figure 2-19: PLGA nano- and microparticles fabricated by the PRINT process. (A) 80 
nm 320 nm cylinders, (B) 200 nm 200 nm cylinders, (C) 200 nm 600 nm cylinders, (D) 1 
11m sphere approximates, (E) 2 11m cubes with ridges, and (F) 3 ~tm particles with center 
fenestrations. Scale bars: (A) 5 !liD, (B) 4 !liD, (C) 3 !liD, (D) 10 !liD, (E) 3 !liD, and (F) 20 
!liD.] 
With a growing interest in top-down fabrication of engineered particles, given the 
advantages detailed above, various approaches have been developed, including 
microfluidics-based methods such as stop-flow lithography (SFL), hard-template 
methods, photolithography-based approaches, as well as imprint lithography approaches 
(Agarwal et al. , 2012; Brown, Smith, & Rennie, 2000; Dendukuri, Gu, Pregibon, Hatton, 
& Doyle, 2007; Shi, Pei, & Li, 2010). Of these top-down fabrication methodologies, 
imprint lithography techniques have gained increasing attention secondary to the 
advantages inherent in the batch processing nature of these techniques including their 
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simplicity, low cost, reproducibility, and potential scalability. Importantly, imprint 
lithography techniques have been demonstrated to produce complex structures with 
reproducible nanoscale features (Qin, Xia, & Whitesides, 2010; Xia & Whitesides, 1998). 
A fundamental , ongoing limitation of the various top-down approaches to particle 
fabrication, including imprint lithography, is the inherent difficulty in scaling to 
economically and industrially appropriate levels, a limitation which is of particular 
importance in nanoscale manufacturing for biomedical applications, as proposed herein. 
In the case of imprint lithography applied to nanomanufacturing, this limitation to 
efficient scaling results, in part, from the inherent need for expensive master molds which 
are typically fabricated using alternative lithographic approaches such as electron beam 
lithography (EBL). 
Two of the most successful imprint-based scalable nanomanufacturing methods 
are the particle replication in non-wetting templates (PRINT) technique (Parrott et al. , 
2012; Rolland et al. , 2005; Rolland, Van Dam, Schorzman, Quake, & DeSimone, 2004), 
and the step and flash imprint lithography (S-FIL) technique (Agarwal et al. , 2012; 
Buyukserin, Aryal, Gao, & Hu, 2009). As shown in Figure 2-20 (A), the PRINT method 
utilizes a proprietary mold material with very low surface energy, then imprint the 
polymer precursor using a roller to realize continuous high throughput manufacturing of 
size and shape specific particles (Figure 2-19). Despite being highly scalable and having 
the capability of manufacturing many different shapes, the master mold still requires EBL 
process. In addition, the fact that details regarding the exact process of the PRINT 
technique are protected by intellectual properties and not widely available in the literature 
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largely limits its accessibility and capacity to be reproduced m different research 
laboratories. 
(A) 
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[Figure 2-20: (A) Illustration of the PRINT method (Canelas et al. , 2009). (B) 
Illustration of the S-FIL method (Glangchai, Caldorera-Moore, Shi, & Roy, 2008).] 
On the other hand, the S-FIL method utilizes a highly specialized step and flash 
nanoimprinter to perfmm repetitive imprints with a mold onto the polymer precursor in a 
grid pattern in order to achieve wafer level particle fabrication, as shown in Figure 2-20 
(B). It is also capable of making size and shape specific polymeric nanoparticles with 
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very high precision. However, similar to PRINT, the requirement of master mold as well 
as the high cost of the nanoimprinter also limits its accessibility. 
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CHAPTER3 
MRI CONTRAST AGENTS 
To demonstrate the potential impact of size, shape, and magnetic property on 
contrast agent design, iron oxide particles with precisely tunable magnetic and geometric 
properties were fabricated using top-down approaches for their use as MRI contrast 
agents. The benefits of such an approach to MRI contrast agents are the capacity for 
multiplexed imaging, diffusion driven signal amplification, as well as the potential for 
functional imaging applications. Following the design of two particle configurations and 
finite element analysis of their internal field distribution with an external magnetic field 
applied, the characterization of various iron oxide thin films with different chemical 
compositions and magnetic properties will be presented. The fabrication processes of 
these particles and their corresponding MRI validation results will subsequently be 
demonstrated. Most of the materials in this chapter were published in Materials Letters 
(Xiaoning Wang, Congshun Wang, Stephan Anderson, & Xin Zhang, 2013), and Sensors 
and Actuators B: Chemical (C. Wang, Wang, Anderson, & Zhang, 2014). 
3.1 Design and Simulation 
3D models representing the proposed contrast agent particles in both 
configurations are shown in Figure 3-1. The double-disk configuration consists of two 
magnetic disks that are separated by a nonmagnetic post, whereas the hollow-cylinder 
particle is made entirely from a magnetic material. For optimum biocompatibility, iron 
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oxide and polyimide were chosen as the magnetic and nonmagnetic materials, 
respectively. 
(A) 
h 
2R 
[Figure 3-1: Two types of contrast agent particle configurations, (A) double-disk and (B) 
hollow-cylinder, with critical dimensions and their relationship to the external field Bo 
marked.] 
When an external magnetic field (Bo in Figure 3-1) is applied perpendicular to the 
post, or parallel to the cylinder wall, the internal field distribution between the disks, or 
within the cylinder, is both homogeneous and distinct from the external field. This local 
alteration in magnetic field is related only to the saturation magnetic polarization of the 
disk material and particle dimensions. Therefore, for thin disks (h << 2S ~ R), the 
precession frequency shift of the hydrogen protons diffused through the particles can be 
approximated as below: 
Eq. 3-1 
where L1w is the frequency shift, y is the gyromagnetic ratio, Js is the saturation magnetic 
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polarization of the magnetic disk, and h, R, and 2S define the geometry: disk thickness, 
radius, and disk-to-disk center separation, respectively (Gary Zabow et al. , 2008; G. 
Zabow & et al. , 2009; Gary Zabow et al., 2009). Similarly, for the hollow cylinder 
particle, the homogeneous field within the cylinder is approximated (for a thin-walled 
structure, t < < H ~ 2R) as: 
Eq. 3-2 
where H, R, and t define the height, outer radius, and cylinder wall thickness, respectively. 
Js is determined by the magnetic moments of the iron oxide thin films per unit mass, 
measured herein using a superconducting quantum interference device (SQUID) at room 
temperature. This top-down approach to magnetic particle fabrication affords a 
multiplexing capability using MRI based on distinct spectral signatures related to the 
particle geometry and/or the material property (Gary Zabow et al. , 2008; Gary Zabow et 
al. , 2009). To date, the fabrication of this novel class of engineered MRI contrast agents 
has utilized nickel and copper as the magnetic and nonmagnetic materials, respectively, 
which, in addition to their suboptimal biocompatibility (Permenter et al., 2011), is also 
limited by the lack of flexibility to tune the spectral signatures of the fabricated pa1ticles 
based on the magnetic properties of nickel. In addition, the relatively large Js of nickel 
may result in exceedingly large frequency shifts, which may impose further limitations 
for subsequent imaging intenogation due to MRI coil design constraints (Doty, 
Entzminger, Kulkarni, Pamarthy, & Staab, 2007). When released from substrates, freely 
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suspended in water and placed in an external magnetic field, both configurations of 
particles can be automatically aligned with the external field, as depicted in Figure 3-1 , 
owing to these structures' innate magnetic shape anisotropy. This is an important 
characteristic, as otherwise it would not be possible for any in vivo applications if these 
particles are not able to self-align with the external magnetic field. 
In contradistinction, iron oxide-based MR1 contrast agents have been widely 
employed for in vivo imaging applications, including in human subjects in their FDA 
approved formulations (Harisinghani et al., 2003; Heesakkers et al., 2008; Ling & Hyeon, 
2013). Other than superior biocompatibility offered by iron oxides and polyimide, the 
range and ease of tunability of possible Js values of the magnetic properties of iron 
oxides yields additional flexibility in the design and resultant spectral signatures of the 
fabricated particles (T. K. Jain et al., 2009). As the discrete frequency shifts of this class 
of fabricated magnetic particles are linearly related to Js, as shown in Eq. 3-1 and Eq. 3-
2, a tunable Js achi.eved by developing deposition techniques and parameters to yield a 
variety of thin film iron oxides would yield an additional degree of freedom in particle 
design. As particle size and shape is being increasingly realized to be a critical factor in 
determining in vivo behavior, such as biodistribution and cellular internalization, it has 
become clear that particle geometry must be optimized for any given application (Geng et 
al., 2007; Sun et al., 2005). Thus, the capacity to employ a fixed, optimized particle 
geometry of this class of multispectral MR1 contrast agents while leveraging the capacity 
to tune the spectral signatures by varying the magnetic properties of the material, is a 
highly attractive feature supporting the use of iron oxides in their fabrication. Finally, the 
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Js range of iron oxides allows for the ability to tune particles' spectral signatures to fall 
within a range optimally interrogated by current MRI hardware. 
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[Figure 3-2: Simulation results demonstrating the homogeneity and distinctiveness of the 
internal field (A, B) between the disks, as well as (C, D) inside the hollow cylinder. (A, C) 
Geometry dependent magnetic field distribution. Red arrows represent the applied 
external field Bo at 11.7 T. (B, D) 2D contour plots of the magnetic field distribution 
along the middle plane between the disks, and within . the cylinder. Yellow dashed 
outlines represent the profile of the disk viewed from the top, as well as the hollow 
cylinder viewed from the side.] 
3D finite element analysis (FEA) was done in the COMSOL Multiphysics 
environment as shown in Figure 3-2. The disks are 200 nm thick, separated by 2 )..tiD, and 
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polyimide posts were omitted for purpose of simplicity. The cylinders have a 5 )..LID outer 
diameter and a 7 )..LID height. An 11.7 T external magnetic field (Bo) was applied along the 
direction of the red arrow to a two-particle system with different disk diameters ( 1 0 )..LID 
and 5 )..LID), and cylinder wall thicknesses (300 nm and 200 nm). Results indicate that the 
field distributions within the particles are homogeneous and distinctive from the external 
field as well as from each other. Magnitude decreases in the field internal to the particles 
versus the external field were approximately 0.1 T and 0.08 T for larger and smaller 
double-disk particles respectively, and approximately 0.1 T and 0.05 T for thicker and 
thinner hollow-cylinder particles, respectively. 2D field distribution was calculated and 
the resulting contour plots are shown on the right. The yellow dashed outline represents 
the shape of the particle. This local field alteration enables the discrete Larmor frequency 
shift resulting in a frequency shifted, distinctive spectral signature, which can be 
validated using MRl (see 3.4 for more details regarding MRl validation). 
3.2 Iron Oxide Thin Films 
Iron oxide thin films with a range of material properties, including magnetism, 
crystallinity, and chemical composition, were deposited using reactive sputtering 
technique to achieve better control over the saturation magnetic polarization (Js). Their 
magnetic properties were then characterized using a superconducting quantum 
interference device (SQUID), their crystallinity was characterized using X-ray diffraction 
(XRD), and their chemical composition was analyzed using energy-dispersive X-ray 
spectroscopy (EDS). 
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3 .2.1 Preparation 
Prior to thin film deposition, <1 00> oriented l-inch silicon wafers were cleaned 
using "Piranha" solution containing 3 parts sulfuric acid (H2S04) and 1 part hydrogen 
peroxide (H202) at room temperature for 15 minutes to remove any organic contaminants, 
followed by submersion in hydrofluoric acid (HF) for 5 minutes to remove the native 
oxide layers. For "Piranha" cleaning, the wafer surface should be relatively clean, and 
completely free from any organic solvents remained from previous wash steps. Iron oxide 
thin films were subsequently deposited using an RF magnetron sputter system (Discovery 
18, Denton Vacuum, NJ, Figure 3-3) from a pure elemental iron target (99.9% purity, 
0.0625 inch thickness, 3" diameter, Kurt J. Lesker, PA) under an oxygen (02) and argon 
(Ar) gas mixture environment to achieve reactive sputtering. Due to the strong magnetic 
permeability inherent with the iron target and in order to maintain the plasma after the 
initial strike, an enhanced cathode housing a double-row magnet configuration built-in is 
necessary to generate a strong enough magnetic field to penetrate through the target and 
thus maintain the plasma during sputtering. It is also important that the Ar flow to be kept 
at a relatively high level, or to be directed towards the cathode if possible, in order to 
maintain the plasma. Note that with the enhanced cathode installed, the remaining two 
standard cathodes will not function normally during sputtering without proper shielding 
in between the cathodes, due to the stronger magnetic field interference from the 
enhanced cathode. Therefore, co-sputtering from multiple targets/cathodes could be 
difficult to achieve. 
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[Figure 3-3: Denton Discovery™ 18 DC/RF Magnetron Sputtering system with ONYX-
3 Mag II enhanced dual magnet cathode from Angstrom Sciences.] 
Sputtering parameters, including RF power, oxygen flow rate (partial pressure), as 
well as substrate heating temperature and post-deposition annealing, were controlled to 
yield varying iron oxide thin films (as listed in Table 3-1). Thin film thickness was 
maintained at approximately 1 J..Lm for most of the samples to ensure an ample amount of 
iron oxide deposited for subsequent characterization, depending on the exact parameters, 
the deposition rate varied from ~ 1 nanometer per second (nm/s) to ~2 nm/s. Argas flow 
rate was kept constant at 25 standard cubic centimeters per minute (seem) for all samples. 
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The base pressure prior to the deposition process was controlled at approximately 1 ~2E-7 
Torr and the bleeding pressure was maintained at approximately 20 mTorr. 
Table 3-1: Sputtering parameters and corresponding weight measurement of the thin film 
samples 
02 
Sample , RF Flow 
Ar 
Flow 
Weight · 
Before 
Weight 
After 
No. ' Power Rate 
Annealing 
Condition Rate , Deposition . Deposition 
[W] ' [seem] [seem] : [Time @ Degree] i [ mg] [ mg] 
1 
------ ---~-------
2 100 2 25 
. 
-----
_ ........ --r----
3 200 2 25 
4 300 2 25 
-----~--... "·---·------~---· .. ·-·-·---- ··-
5 200 3.5 25 
---6 ·-'-200 -·---4 -· ,··-·2-s·----,--
~ ; 
273 .541 
291.93 
277.673 
291.346 
252.996 
282.613 
276.884 
295.217 
-----------·-·-·- ·-·-··---;--·---·-··-~------------- ---·. ·-· --· 
25 : 255.747 258.986 7 200 . 5 
------. ---·--- ·-k-·-~-- ,-- -- ---- - --- -
8* 
9* 
200 
200 
5 25 : 2 hours @ 100°C : 269.274 272.527 
------1----
5 25 2 hours @ 200°C 269.274 
10** 200 5 25 2 hours @ 300°C 253.285 
-----'---~ .,._ .. _.._.. ___ ....... ~ ... . ,,_ ... __ ....... -? 
11 ** 200 5 25 i 2 hours @ 400°C ' 253.285 
-·-~- - -- - -... -- ... , .... ..,,.,.:..... ...... _._.-
12 200 0 25 280.267 
272.527 
256.563 
256.563 
283.429 
* Sample 8 and 9 were from the same wafer that was split in half before annealing, 
therefore have the same weight before and after deposition. 
* * Sample 1 0 and 11 were from the same wafer that was split in half before annealing, 
therefore have the same weight before and after deposition. 
Because magnetic property characterizations requires knowledge of the total mass 
of the deposited materials, each wafer was weighed before and after deposition using a 
ME36S Microbalance (Sartorius AG, Germany). Post deposition annealing was done (not 
on all the samples) using a rapid thermal annealer (RTP-600S, Modular Process 
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Technology Corp., CA) under a nitrogen (N2) environment for two hours at various 
temperatures. As a comparison (Sample 1 and 12), pure iron thin films were deposited by 
both sputtering without the 02 gas flow as described above, as well as using electron 
beam (e-beam) evaporation (Auto 360 Turbo, Edward's Vacuum, NY) from iron pellets 
(99.95% purity, 1/8" diameter by 1/8" height, Kurt J. Lesker, PA) at ~ 1 angstrom per 
second (A/s). 
3 .2.2 Characterization 
A SQUID magnetometer (MPMS-5S, Quantum Design Inc., CA) was used to 
measure the magnetic properties of the iron oxide thin films, as shown in Figure 3-4. The 
magnetometer is capable of performing measurements of magnetic moments (J) in the+/-
2 emu range with a resolution of 10-7 emu, and may be obtained in the temperature range 
of 1.8 to 1000 Kelvin (K) with magnetic fields ranging from -5 T to +5 T. In the 
particular case herein, magnetic moment measurements were performed at room 
temperature (300 K), and the range of field strength applied were between 0 to 5 T. The 
thin film samples were cut manually into rectangular pieces of approximately 5 mm x 7 
mm in size and were inserted into a plastic straw* (7.75" Transparent Jumbo Straw, 
STW-177-SYS, SYSCO, TX) and placed in parallel with the applied field inside the 
testing chamber of the SQUID. 
* Due to the extremely sensitive nature of the magnetometer, this particular brand of straws 
needs to be used as the sample holder, since the original calibration was done with it, according to 
the scientist in charge at the Center for Material Science and Engineering at MIT. 
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[Figure 3-4: Quantum Design Magnetic Property Measurement System (MPMS-5S 
SQUID Magnetometer). Several thin film samples placed in plastic straws ready for 
SQUID experiment.] 
To account for the background signals generated from the silicon substrates 
present with all the iron oxide thin film samples, the magnetic moment response curve 
from a bare silicon chip was also measured under the same conditions. It was found that 
the diamagnetic* contribution from the silicon background was in the low 1 o-6 emu range, 
therefore its effect could be safely neglected during data processing. 
* Diamagnetic materials create a magnetic field in opposition to an externally applied magnetic 
field. It is a quantum mechanical effect that occurs in all materials, usually very weak. 
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Magnetization data of each sample was nmmalized to emu/mg based on the mass 
of the thin film on chip, as listed in Table 3-1 and Table 3-2. The mass of iron oxide and 
silicon per chip can be simply calculated by: 
Eq. 3-3 
Eq. 3-4 
where lnbefore, lnafter, lnchip, mFeOx and ms; represent the mass of: the wafer before 
deposition, the wafer after deposition, the sample chip for SQUID measurement, the iron 
oxide on the sample chip, and the silicon on chip, respectively. Due to the limitations of 
the SQUID magnetometer, the magnetic moments of the iron oxide thin films cannot be 
directly measured at 11.7 T, which was the operating field strength of the MRI scanner 
later used to validate the contrast agent particles. However, as shown in Figure 3-5, all 
samples exhibited saturation or near-saturation magnetization approaching 5 T and the 
magnetic moments at higher fields were thereby extrapolated to 12 T, demonstrated as 
black dashed lines, to obtain Js values at the desired field strength 11.7 T. 
Table 3-2: Weight data of the sample chips for SQUID measurement 
Sample 
No. 
Total 
Mass 
Deposited 
[mg] 
Chip 
Weight 
[mg] 
Iron Oxide 
Weight per 
Chip 
[mg] 
Silicon 
Weight per 
Chip 
[mg] 
1 * 0.546 25.871 0.051 25.820 
_, ... ,._. .. ............. ~ ..... · ... ~ ............ ".~" ·' ,. __ _. _ ----~-- ~ .. ,. ............... __ .... -.. _ ... _ . ..,. ........... __ ,_._ ... _ ........ ___ . --
2** 1.67 27.286 0.156 27.130 
---- -·- ---------- ·,- ---- -·-t-· 
3 3.204 19.568 0.248 1 19.320 
-~-- -- --- --~---- _______ ,.. ______ --
-----
4 3.411 31.668 0.382 31.286 
----·----·· ---------·--·---- --·-----··-·----··:--------
5 3.343 22.592 0.273 22.319 
. ----·-·-__j_ --
55 
---- ~ -- -•W ------- ·------
6 3.287 26.351 0.293 26.058 
7 3.239 16.148 0.202 15.946 
8 3.253 23.406 0.279 23.127 
_ ...... 
---.... - -·-.. -· --- ... ..... --.. .. ,_,.., ...... ~···-------·--r---~ .. 
9 3.253 17.511 0.209 17.302 
10 3.278 21.639 0.276 21.363 
-----
-
11 3.278 13 .378 0.171 13.207 
---
12 3.162 23.423 0.261 23 .162 
* The chip weight was mainly dependent on its size, which was cut manually, hence the 
variation. 
**Sample 1 was deposited using e-beam evaporation, with 200 nm film thickness. 
*** Sample 2 was deposited at a low deposition rate due to low RF power. 
The raw data from SQillD consists of the longitudinal magnetic moment [emu] 
measured from the sample at a range of pre-defined external magnetic field strengths 
[Oe] . Each data point was averaged from 64 scans, with a standard deviation in the 10-5 
to 10-6 emu range. An example data set of Sample 12 is given in Table 3-3. The 
normalized longitudinal magnetic moment [ emu/mg] data was calculated rather than 
directly measured: 
M = Mmea.l' l/ ted 
nomwlized 
111Fe0x 
Table 3-3: Example SQUID data set of Sample 12 
Field 
[Oe] 
0 
250 
Longitudinal 
Temperature Moment 
[K] [emu] 
299.9912 -0.00821 
300.0235 0.03309 
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Longitudinal 
Scan 
Standard 
Deviation 
5.52E-06 
3.50E-06 
Eq. 3-5 
Normalized 
Longitudinal 
Moment 
[emu/mg] 
-0.03143 
-
0.12665 
500 
1000 
1500 
2000 
2500 
3000 
3500 
4000 ' 
5000 
6000 
7000 
8000 
10000 
20000 
30000 
299.9678 
299.9678 
299.9588 
299.9498 
0.04108 
0.04559 
0.04719 
0.04792 
299.966 0.0483 
299.9444 0.04853 
.... -.-.. - -~ ...... --
299.9499 0.04868 
299.9642 0.04879 
299.9912 --r 0.04896 
300.0289 
299.9067 
299.9984 
299.9157 
299.9732 
299.9839 
0.04906 
0.04914 
0.04921 
0.04932 
0.04958 
0.04968 
... _ .. _1_ .. --·-"-~ -~ ----- --·-·· 
40000 
50000 
299.9301 
300.0666 
0.04972 
0.04975 
5.11E-06 
7.33E-06 
2.49E-06 
---
1.21E-05 
8.77E-06 
2.70E-07 
1.45E-05 
·- -
9.14E-06 
1.66E-05 
3.31E-06 
7.91E-06 
7.00E-06 
0.15721 
-
t-
0.1745 
0.18062 
0.18341 
0.18487 
0.18573 
0.18633 
0.18673 
0.18737 
~--o.187n-
t- _9_.188o~ 
0.18836 
0.18877 
0.18975 
0.19013 
0.19031 
0.19042 
The saturation magnetic polarization Js [T] is calculated using the following 
equations (for details on unit conversion, also refer to Appendix A.1): 
Eq. 3-6 
J s [emu/ cm3 J = M normatized [ emu/mg]x P[ gj cm3 Jx 103 Eq. 3-7 
where p is the density of iron oxide, depending on the exact phase of the iron, iron (II) 
oxide (FeO) has a density of 5.745 g/cm3, iron (III) oxide (Fe203) has a density of 5.242 
g/cm3, and iron (II, III) oxide (Fe304) has a density of 5 g/cm3 (Wikipedia). Since these 
reactively sputtered iron oxide thin films oftentimes consist of a mixture of multiple 
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phases of iron and iron oxide, as evident from the XRD and EDS characterization results 
below, an accurate density data cannot be detetmined conclusively. Therefore, only the 
normalized longitudinal magnetic moment data was plotted in Figure 3-5 , and the 
saturation magnetic polarization value can be estimated if necessary, by using the upper 
and lower bounds of the various iron oxide density values. 
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[Figure 3-5: Magnetization curves of the magnetic moment, normalized to emu/mg, at 
room temperature from 0 T to 5 T of various iron/iron oxide thin film samples prepared 
under different sputtering parameters, as well as the extrapolated high field response up 
to 12 T.] 
58 
[Figure 3-6: Bruker AXS D8 Discover Advanced X-ray Diffraction System.] 
The nmmalized magnetic moment measurement curves demonstrated the 
transition from ferrimagnetic to ferromagnetic propetiies with ttmable saturation 
magnetization ranging from ~0.05 emu/mg to ~0 . 19 emu/mg, as shown in Figure 3-5, 
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with Sample 7 and 8 being the lowest (overlapped) and Sample 12 being the highest. 
Higher deposition power and lower oxygen partial pressure both resulted in a higher 
saturation magnetization. In addition, increasing annealing temperature above 200 oc 
was also found to significantly increase the saturation magnetization. It is also worth 
pointing out that variations between samples prepared under similar conditions were 
minimal (within 5%), such that the reactive sputtering technique demonstrated herein 
represents a reliable and effective way to control the magnetic properties of iron oxide 
thin films. 
:::l 
ctS 
-
#2: 202 
100W 
#3: 202 * 
200W 
#4: 202 
300W 
[J #11: * }:::{ • [J 
400oc 
• • 
10 20 30 40 50 60 70 80 10 20 30 40 50 60 70 80 90 
29(degree) 29(degree) 
[Figure 3-7: XRD spectrum of the iron oxide thin film samples. Peak legends: * a-
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Fe203, + Fe, <> Fe304, o Si.] 
XRD analysis was done using an X-ray diffractometer (Bruker AXS D8 Discover, 
WI; Figure 3-6). Diffraction spectra were acquired under Cu Ka radiation ('A~1.5406A) 
with 40kV and 40mA source settings. Apart from a few thin film samples with nano-
scale crystalline structure, as shown in Figure 3-7, a mixture phase of Fe, a-Fe203, and 
Fe304 was observed in most of the thin films with one dominant phase depending on the 
deposition parameters (Joong Kim, Moon, Lee, & Jung, 2000; Miller, Paluselli, Marsen, 
& Rocheleau, 2004). 
EDS experiments were also performed usmg a JSM-6100 scanning electron 
microscope (JEOL Ltd., MA) equipped with an EDS detector (Oxford Instruments, MA) 
with 15k V accelerating voltage and 15mm working distance to obtain successful 
elemental analysis for 0 , Si, and Fe. The data shown in Figure 3-8 demonstrates high 
purity thin films with positive correlations between iron atomic concentrations and the 
corresponding saturation magnetizations (Mnormalized). Scanning electron microscopy 
(SEM) images (Zeiss Supra 55VP, Carl Zeiss NTS, MA) in Figure 3-9 showed the 
morphological changes of the thin film sample (No. 11) due to annealing at 400 oc for 2 
hours under N2 environment, demonstrating a significant increase in grain size, and much 
clearer grain boundaries, as was confirmed by XRD data in Figure 3-7. Both XRD and 
EDS results were highly reproducible and negligible inter-sample variations were 
observed. 
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[Figure 3-8: EDS spectrum of the iron oxide thin film samples.] 
A Phi-Rho-Z correction procedure was used for all specimens m the EDS 
quantitative analysis, and the atomic concentrations and corresponding deposition 
parameters are listed in Table 3-4, which correlate well with the area-under-the-curve of 
various peaks in Figure 3-8. The reproducibility of these characterization results was 
assessed by repeating experiments on different iron oxide thin film samples prepared 
under similar or identical deposition parameters. · 
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Table 3-4: Sputtering parameters and conesponding atomic concentrations of the thin 
film samples 
Sample RF 
No. Power 
02 
Flow 
Rate 
Annealing 
Condition Atomic Concentration [at. %] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
[W] [seem] [Time @ Degree] 0 
100 2 
200 2 
300 2 
200 3.5 
200 4 
200 5 
200 5 
200 5 
200 5 
200 5 
200 0 
_ 1 32.17 8.63 * 
_
1
1 23.59 o.33 
12.08 0.21 
-·--- 1 25.77 o.13 
-_ --. - · 1 36.6-7 o.14 
- -- -14 5.-18 . 0.17 
2hours @1ooac I 46.13-- 0.19 
2 hours @ 200°C I 45 .05 - 0.15 
2 hours @ 300°C I 46.89 . O.l5 
- 2-ho~·~ -@ 4ooac-1 44~85 - ... 012-
- -- 1 5.91 ** o.21 
Fe 
59.2 
76.08 
87.71 
74.1 
63.19 
54.65 
53.68 
54.8 
52.96 
55.03 
93.82 
Fe/0 
1.84 
3.23 
7.26 
2.87 
1.72 
1.21 
1.16 
1.22 
1.13 
1.23 
15 .87 
* X-ray beam penetrated deeper into silicon substrate due to low deposition rate for this 
particular iron oxide thin film sample. 
**Due to absorption of free oxygen in the film surface. 
[Figure 3-9: SEM images showing the surface morphology changes of the iron oxide 
thin film (sample before (left) and after (right) armealing at 400 °C for 2 hours.] 
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3.3 Particle Fabrication 
Particle fabrication was unde1iaken after the thin film studies, so that the 
deposition parameters could be used to produce the desired type of magnetic thin films. 
All of the fabrication processes were using standard top-down techniques that are 
available to most cleamooms in research labs or foundries that are able to scale up to 
production level, except the electron beam lithography (EBL) procedure for fabricating 
the nano-scale hollow-cylinder particles, which is a more time consuming and low-
throughput, serial process. 
3.3.1 Double-disk 
Similar to the preparation before thin film deposition, 2-inch <1 00> oriented 
silicon wafers were cleaned using standard "Piranha" solution for 15 minutes, then 
dipped in HF for 5 minutes to remove the native oxide layer and dried in a convection 
oven under N2. Hexamethyldisilazane (HMDS, Shin-Etsu MicroSi, Inc., AZ) was spin-
coated at 4000 rounds per minute (rpm) for 45 seconds to promote adhesion between the 
photoresist and the substrate. Image reversal of positive tone photoresist AZ5214E (AZ 
Electronic Materials, NJ) was used to pattern the photoresist before depositing iron oxide 
disks to form a "negative" of the desired disk array pattern. The photoresist was spin-
coated at 4000 rpm for 45 seconds, soft baked on a hotplate at 110 oc for 1 minutes, 
subsequently exposed using a mask aligner (Karl-Suss MA6, SUSS MicroTec, CA) under 
365 nm wavelength UV light at 10 mW/cm2 for 4.5 seconds, hard baked at 120 °C for 2 
minutes on a hotplate, and finally, "flood" exposed for 60 seconds using the previous 
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exposure settings to reverse the tone of the photoresist. Afterwards, the wafer was 
developed in AZ400K developer (Diluted 1:4, AZ Electronic Materials, NJ) for 15 
seconds, and underwent a descum process in a plasma asher (M4L, PVA TePla, CA) 
using 5 seem oxygen at 50 W for 30 seconds.· Iron oxide thin film was then deposited 
using the RF magnetron sputtering system tmder the same conditions as described 
previously depending on the desired saturation magnetic polarization. The deposition rate 
of a given set of sputtering parameters should be calibrated first on a dummy wafer prior 
to the actual process. Another sacrificial layer may readily be deposited underneath the 
iron oxide for futme pmiicle release purposes. 
• • • 
• • • • • • • • • 
• • • • • •• 
• • • 
--~ 
--~ 
Substrate FeOx • Polyimide 
• Photoresist • Sacrificial layer 
[Figure 3-10: Fabrication process of the double-disk microparticle arrays, including two 
photolithography and lift-off steps to pattern the top and bottom disk, and RIE etching the 
polyimide post.] 
As illustrated in Figure 3-10, after lift-off the photoresist layer in an acetone bath 
under ultrasonication, polyimide (PI2610, HD Microsystems, NJ) was spin-coated (3500 
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rpm for 30 seconds) on the wafer, resulting in complete coverage of the bottom iron 
oxide disks. The wafer was then baked on two hotplates at 90 oc for 90 seconds and 
150 oc for 90 seconds respectively, before curing in the RTP-600S rapid thermal 
processor at 350 oc for 30 minutes with a ramping rate of 4 °C/minute. 
The top iron oxide disks were pattemed using the same lift-off process as the first 
layer except that the photomask had to be carefully aligned with the bottom disks using 
the MA6 mask aligner to ensure a resultant homogeneous magnetic field distribution 
profile. Two steps of reactive ion etching (RIE) with 40 seem 02 and 10 seem 
tetrafluoromethane (CF4) at 200 mTorr chamber pressure were used to etch the polyimide 
to form the vertical, slim post between the iron oxide disks. Anisotropic etching was 
achieved at 85 W RF power for approximately 5 minutes to form the "magnetic-
polyimide-magnetic sandwich" structure, immediately followed by lowering the RF 
power to 25 W while maintaining all other parameters to achieve isotropic etching profile 
of the polyimide. The duration of the second etching step required calibration and precise 
timing control to ensure that the desired slender polyimide post remained robust enough 
to support the top disk, a rough estimate was 1 7 minutes for the 1 0 !liD diameter particles, 
and 8 minutes for the 5 11m diameter pmiicles. 
Polyimide was chosen as the non-magrietic spacing material, rather than copper as 
previously reported (Gary Zabow et al. , 2008), given its biocompatibility (Richardson Jr, 
Miller, & Reichert, 1993). Beyond polyimide, other biocompatible polymers may be 
considered for integration into this class of MRI contrast agents, such as 
polydimethylsiloxane (PDMS), poly(methyl methacrylate) (PMMA), and SU-8 (Cho et 
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al., 2008; Folch & Toner, 1998; Frazer, Byron, Osborne, & West, 2005). In addition, 
hydrogels may be considered for use as a non-magnetic spacing material which, given 
their adjustable water content and diffusion coefficients, may be suitable spacing 
materials which do not necessitate an inherently thin profile, possibly leading to 
improved particle robustness (Betancourt & Brannon-Peppas, 2006; McConville & Pope, 
2000). Furthermore, by incorporating environmentally responsive hydrogels as the 
spacing material, such as a pH responsive poly( ethylene glycol)dimethacrylate (PEG-
DMA) (Gil & Hudson, 2004), or an enzyme degradable peptide crosslinked poly 
(ethylene glycol) diacrylate (PEG-DA) (Glangchai et al. , 2008), this class of MRI agents 
may be further developed as pH or enzyme sensors for use with MRI. 
-1m 
(C) -6~m (D) 
[Figure 3-11: SEM images demonstrating fabrication results of two different sizes of 
rnicroengineered iron oxide double-disk particles (A, C) and their arrays (B, D).] 
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Particle arrays with 5 ).Lm to 10 J..lm disk diameter, 100 run to 300 run thickness 
and ~2.2 ~tm disk-to-disk separation were successfully fabricated, as shown in Figure 3-
11. The diameter cif the resulting polyimide posts were controlled to be roughly 500 run 
at the upper aspect of the post, and ~ 700 run at the bottom (resulting in post-volumes of 
0.4% and 1.4% ofthe total internal diffusing volume of the 5 J..lm and 10 J..lm double-disk 
particles, respectively) for all disk diameters to ensure particle robustness for MRI 
experiments (see Figure 3-20 in 3.4). Note that there were residues left on the bottom 
disk which resulted from polyimide etching that were not seen to affect the subsequent 
MRI validation. 
[Figure 3-12: The outer layer of polyimide was "burnt" when the RF power was set too 
high during RIE.] 
Also worth pointing out is that during the etching of the polyimide using RIE, a 
high RF power (above 100 W) would result in "burnt" residues of the polyimide at the 
perimeter of the particles that were very difficult to remove, as can be seen in Figure 3-
12. The tunability of this new class of contrast agents not only stems from the 
engineering flexibility to vary structural dimensions, but also the material properties of 
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the iron oxides themselves, since the thin films incorporated into the aforementioned 
fabrication process may be readily varied using the specific thin film deposition 
parameters developed in this dissertation. 
3.3 .2 Hollow-cylinder 
(B) 
Substrate - Sacrificial Layer 
[%~~~~ Photoresist FeOx =::: lon Milling 
[Figure 3-13: Fabrication process of the hollow-cylinder configuration particle arrays at 
(A) micro-scale, using photolithography, and (B) nano-scale, using e-beam lithography.] 
Hollow-cylinder particles were fabricated at both micro- and nano-scales, using 
photolithography and e-beam lithography techniques, respectively, as shown in the 
process flows in Figure 3-13. In the case of hollow-cylinder microparticle arrays, AZ 
P4620 photoresist (AZ Electronic Materials, NJ) was spin-coated on a "Piranha" cleaned 
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silicon wafer at 3000 rpm for 60 seconds after HMDS coating, yielding an approximately 
8 !-liD thick photoresist layer. Subsequen~ly, the coated wafer was soft-baked at 90 oc for 
90 seconds, before being exposed to UV light (10 mW/cm2 for 40 seconds) through a 
photomask and developed in AZ400K for 120 seconds, forming thick photoresist pillars 
on the wafer surface. 
For depositing 1ron oxide thin films, the previously described RF reactive 
sputtering process was used with 2 seem 02 and 25 seem Ar gas flow rates and 200 W 
RF power at room temperature. This sputtering process can yield good confmmity, 
thereby ensuring side wall coverage. Similar to the sputtering step in the double-disk 
configuration fabrication, the deposition time needs to be calibrated and controlled to 
achieve the desired side wall thickness of the cylinder. Next, the wafer was etched using 
highly directional Ar ion milling with a beam current of ~ 100 rnA to remove all of the 
up-facing iron oxide layers. During the ion milling, a pmiion of the iron oxide and a 
fraction of the silicon ejected from the substrate were re-deposited on the pillar sidewall. 
This additional redeposition also serves to make the cylinder more robust with improved 
reliability. Finally, the photoresist was fully removed using 02 plasma ashing under 300 
W power and 300 seem gas flow rate. 
In the case of the nanocylinder patiicle fabrication, a similar iron oxide RF 
reactive sputtering and an ion milling process was pursued on a resist layer with patterned 
holes as opposed to the pillars employed above. Firstly, e-beam resist (PMMA 950 A4, 
MicroChem, MA) was spin-coated on a pre-cleaned silicon wafer at 3000 rpm for 45 
seconds after HMDS spin-coating, yielding an approximately 200 nm thick PMMA layer. 
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Subsequently, after soft bake at 180 oc for 5 minutes, the coated wafer was exposed to 
the electron beam (250~350 )..LC/cm2 dosage) through an e-beam writer (Zeiss Supra 
40VP, Carl Zeiss NTS, MA) followed by developing for 50 seconds in the developer, 
composed of methyl isobutyl ketone (MIBK) to isopropanol (IP A) volume ratio 1:3 , and 
subsequently rinsed in IP A for 20 seconds, forming a patterned array of PMMA holes on 
the wafer surface. The diameter of the patterned holes was 150 nm with a center-to-center 
distance of 600 nm. Iron oxide thin film was subsequently sputtered onto the wafer, 
covering all of the exposed surfaces, including the sidewall of the PMMA holes . As 
above, for depositing iron oxide thin films, RF reactive sputtering with similar parameters 
as those employed for the micro-scale cylinder fabrication were utilized. A similar ion 
milling step was subsequently employed with the PMMA finally removed using 0 2 
plasma ashing. 
[Figure 3-14: (A) SEM images demonstrate fabricated hollow micro-cylinder with ~8 
)..till outer diameter, ~8 )..till height and ~200 nm cylindrical wall thickness; (B) hollow 
micro-cylinder anay.] 
Utilizing the micro-scale process flow (Figure 3-13 A), biocompatible hollow-
cylinder arrays with ~8 )..till outer diameter, ~8 )..till height and ~200 nm cylindrical wall 
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thickness were successfully fabricated as shown in Figure 3-14, verifying the feasibility 
of the microfabrication process on hollow-cylinder arrays. RF sputtering was found to 
provide coverage of all exposed surfaces, including the sidewall of the photoresist pillar, 
by the iron oxide thin film. The subsequent ion milling step was employed to remove the 
iron oxide along the upward-facing surfaces of the pillars and the underlying substrate, 
while redepositing additional iron oxide onto the sidewalls of the cylinder, further 
improving cylinder robustness. 
-1pm 
[Figure 3-15: SEM image of a photoresist pillar after RF reactive sputtering, 
demonstrating iron oxide thin film coverage of all exposed surfaces.] 
An important consideration with the use of ion milling is the potential for non-
uniform redeposition of the iron oxide during this fabrication step (K. P. MUller & Pelka, 
1987). In the case of the micro-scale particles, as the deposition of the iron oxide was 
relatively uniform prior to the ion milling step (Figure 3-15), concerns regarding a loss 
of uniformity seem unwarranted, however, this may be due to the relatively small scale of 
the degree of nori-tmiformity of redeposition when compared to the cylinder size at this 
scale. 
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[Figure 3-16: (A) SEM images demonstrate fabricated hollow nanocylinders with ~150 
nm outer diameter, ~200 nm height, and ~20 nm wall thickness; (B) hollow nano-
cylinder anay.] 
In the case of the nano-scale cylinders, it is hypothesized that a non-uniform 
redeposition during ion milling may serve to counteract a non-uniform deposition during 
the RF sputtering process using the nanohole arrays. That is, the ion milling step, 
resulting in preferential redeposition of the iron oxide at the base of the nanoholes may 
serve to balance the preferential deposition of the iron oxide along the top of the 
nanoholes during RF sputtering, thereby yielding uniform cylindrical structures. As 
shown in Figure 3-16, nano-scale hollow-cylinder arrays with ~150 nm outer diameter, 
~200 nm height, and ~20 nm wall thickness were successfully fabricated. As noted above, 
an 02 plasma etching step to remove the photoresist after the final hollow-cylinder 
formation was employed, thereby avoiding the potential physical damage from an 
alternative wet etching-based approach. This dry resist stripping step is felt to be 
important to ensure the precise cylinder geometry, especially on the nano-scale. Another 
important consideration supporting the use of 02 plasma is the avoidance of potential 
chemical contamination, a possible limitation of a wet etching approach, especially for 
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biomedical applications. 
While not specifically addressed herein, future translation of these hollow-
cylinder particles requires their eventual release from the substrates employed in the 
fabrication process. Prior works have employed a sacrificial gold layer which, following 
particle fabrication using nickel, allows for chemical wet etching of this underlying layer 
to yield particle release (G. Zabow & et al., 2009). In the case of iron oxide, an 
alternative sacrificial layer is required to minimize iron oxide etching during the release 
process; considerations include the use of polyimide as a sacrificial layer (Bagolini et al., 
2002). Furthermore, the use of potassium hydroxide (KOH), a commonly employed 
etchant of silicon, is an alternative consideration in releasing the fabricated iron oxide 
particles in the absence of an underlying, dedicated sacrificial layer. 
3.4 MRI Validation 
For the purposes of validating the distinct spectral signatures of the particles, 
arrays of fabricated particles on silicon substrate were analyzed with an 11.7 T MRI 
scanner (Avance 500 MHz UltraShield™, Bruker BioSpin, MA; Figure 3-17). Using a 
20 mm diameter birdcage coil (Figure 3-18), 7.5 mm x 7.5 mm chips with arrays of 
fabricated double-disk magnetic particles were placed in a custom made sample holder 
(Figure 3-19) such that the particles were immersed and sealed in a limited amount of 
water, approximately 0.8 microliter (!lL), or less than 200 )liD depth above sample surface, 
thereby limiting the signal generated from the background fr·ee water pool. Alignment 
was also made easy with this sample holder so that the external magnetic field (Eo) is in 
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parallel with the magnetic disks when being placed into the magnet. 
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[Figure 3-17: Bruker Biospin A vance 500 MHz UltraShield™ NMR Spectrometer.] 
[Figure 3-18: (A) A selection of birdcage coils with different diameters, the horizontal 
line marks the position to center the sample at the optimum external field location. (B) 
The insert that will place the coil inside the main magnet of the MRl scanner. 
(Queensland)] 
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[Figure 3-19: (A) Several 7.5 rnm x 7.5 rnm samples ready for MRI testing. (B) Custom 
machined polycarbonate horizontal sample holder with a ~ 170 !-!ill well (C) to hold the 
double-disk sample chip in place with limited amount of surrounding water.] 
An indirect detection pulse sequence, which included a series (n=:8000, time 
between pulses=1ms) of off-resonant pulses (Gaussian shape, length=125 !-!S) was swept 
through a range of frequencies, including the predicted frequency offset of the particle 
anay, followed immediately by an on-resonant excitation pulse for the collection of free 
induction decay (FID) signals, was employed herein. If the off-resonant pulses were close 
to · the frequency shift of the particle anay, the proton spins of the water molecules 
diffusing through the particles would be excited and their magnetization flipped into the 
transverse plane. Given that their magnetization was primarily in the transverse plane, 
their resultant signal following the on-resonant excitation pulse was significantly 
diminished, thereby effectively reducing the collected FID signals at the frequency shift 
of the particles. The data from the FIDs collected over the range of frequencies was 
utilized to construct z-spectra, shown in Figure 3-20 (A), demonstrating two distinct 
spectral signatures predicted using Eq. 3-1 , given the measured Js of the magnetic thin 
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films employed in the fabrication process, as well as the dimensions of the particles. 
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[Figure 3-20: (A) Sample Z-spectrum from two fabricated double-disk particle arrays 
submerged in water, demonstrating frequency dependent saturation responses at 
approximately -1.1 MHz and -400 KHz. (B) A double-disk particle array sample before 
MRI experiment. (C) The same sample after MRI experiment shows pa1iial collapse of 
the top disks.] 
The samples were examined usmg SEM before and after MRI validation 
experiment to verify the robustness of the particles. As shown in Figure 3-20 (B) and (C), 
· one of the double-disk particle array sample chips, due to the thickness of the polyirnide 
posts, partial collapse of particles was observed, suggesting the need to optimize post 
thickness to balance particle robustness and MRI signal generating capacity. In practice, 
for the 10 !liD diameter double-disk particles fabricated in the previously described 
process, polyimide posts thinner than 300 nm were not robust enough to ensure particle 
integrity after MRI validation. 
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[Figure 3-21: Sample Z-spectrum from a fabricated hollow-cylinder particle anays 
submerged in water, demonstrating frequency dependent saturation response at 
approximately-700KHz.] 
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[Figure 3-22: (A) Custom machined polycaTbonate vetiical sample holder with a ~ 170 
J.lm well (B) to hold the hollow-cylinder sample chip in place with limited amount of 
sunounding water.] 
Similar validation result was achieved for hollow-cylinder microparticle arrays, as 
shown in Figure 3-21 . A different chip holder (Figure 3-22) is required due to the fact 
that the orientation of the sample chip needs to be ve11ical to Bo, as oppose to parallel for 
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the double-disk configuration. Post-MRI examination revealed much better robustness 
compared to double-disk particles, which was expected based on their geometrical 
differences. 
Although validation experiments were done without releasing the particles from 
the substrate, similar results were already reported by Zabow et al. in several publications 
(Gary Zabow et al., 2008; G. Zabow & et al., 2009; Gary Zabow et al., 2009). The main 
contribution of this dissertation is the utilization of biocompatible materials, including 
iron oxide and polyimide, into the design and fabrication of this novel class of contrast 
agents for their potential in vivo applications, as well as the ability to control the magnetic 
properties of the iron oxide to achieve better MRI performance. 
3.5 Summary and Discussion 
In summary, the design, material characterization, particle fabrication and MRI 
validation of precisely engineered MRI contrast agents were reported herein. Reactively 
sputtered iron oxide thin films with controllable saturation magnetic polarization were 
employed in the top-down fabrication of two types of biocompatible MRI contrast agent 
micro/nanoparticles with geometry and magnetic property-dependent, tunable MRI 
spectral signatures. This tmique approach enables the possibility for multiplexed imaging 
in MRI, as well as a diffusion-driven signal amplification and the potential for 
functionalization. Several aspects, including the potential for functionalization, the in 
vivo applications, as well as the manufacturability, will be discussed hereafter. 
3.5.1 Functionalization Potential 
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As the unique spectral signatures as well as the signal strength of the fabricated 
particles are related to the precise geometry of their structure and the internal diffusion of 
water, respectively, any change in geometry or rate of diffusion would result in a change 
in the measured MRI signal. If an environmentally responsive material, incorporated-into 
the particle, was responsible for limiting the diffusibility of water through the fabricated 
particles' internal volume, the MRI signal strength would be modulated based on the 
environmental factor to which the responsive material was sensitive. Alternatively, if the 
precise geometry of a patiicular particle was supported by an environmentally responsive 
material, a change or disruption of the geometry in response to the particular stimuli 
would yield an MRI measurable change in the unique spectral signature. 
Hydro gels represent a diverse field of materials with myriad properties, including 
the ability to respond to specific local environmental factors (Klouda & Mikos, 2008; 
Ming Lei, Yuandong Gu, Antonio Baldi, Ronald A. Siegel, & Babak Ziaie, 2004a; Ming 
Lei, Yuandong Gu, A. Baldi, R. A. Siegel, & B. Ziaie, 2004b; Miyata, Asami, & Uragami, 
1999; Qiu & Park, 2001; Yew, Ng, Li, & Lam, 2007; Ziaie & Siegel, 2004). Hydrogels 
are finding increasing application in biomedicine, including targeted drug delivery, 
advanced, responsive medical devices and diagnostics. Hydrogels have been developed to 
be responsive to a wide variety of environmental parameters including pH, temperature, 
as well as the presence of various enzymes or specific proteins. Hydrogels have been 
incorporated into NEMS and MEMS patterning processes for their use in biomedical 
applications (Cong, Revzin, & Pan, 2009; Lei et al., 2004a; Lei et al., 2004b; Yew et al., 
2007; Ziaie & Siegel, 2004). 
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[Figure 3-23: Possible scenanos for hydrogel integration. (A, B) Protease sensor: 
diffusion rate will increase when the hydrogel dissolves under the presence of certain 
protease. (C) pH or temperature sensor: the spectral signature will change due to 
increase/decrease in disk spacing in high/low pH environment. (D) Protease sensor: 
particle will disintegrate with the presence of certain protease.] 
Figure 3-23 demonstrated several example scenarios of how hydrogel can be 
incorporated into the MRI contrast agent particles to yield functional MRI contrast agents, 
realizing an in vivo MRI sensing capability. Specifically, the ability to measure tissue pH 
using MRI in vivo would have numerous clinical applications, including the possibility of 
further developing an understanding of tumor biology and increasing diagnostic accuracy 
in detecting tumors known to have acidic extracellular environments (Gullotti & Yeo, 
2009; Y. Shen, Tang, Radosz, Van Kirk, & Murdoch, 2008). In cell tracking applications, 
the ability to monitor pH offers the potential to monitor cell viability given changes in 
intracellular pH during cell death (Marches, Vitetta, & Uhr, 2001 ). 
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Additionally, the capability of monitoring protease activity in vivo would also 
have myriad clinical applications given the upregulation of protease activity in numerous 
disease states including inflammation as well as malignancies. In addition to numerous 
conceivable nano-scale molecular imaging applications of the capacity for in vivo 
protease sensing, the response to specific proteases confers the potential for cell viability 
and ftmctionality sensing in cell tracking applications (Tardy, Tyynela, Hasilik, Levade, 
& Andrieu-Abadie, 2003). 
3.5.2 Size and Applications 
Although currently all of the MRI validation experiments were perfonned in vitro, 
it is worthwhile to consider the potential in vivo biomedical imaging applications of these 
particles as a factor of particle size. While micro-scale pmiicles ofthis nature are unlikely 
to be appropriate for intravenous administration, as is routinely preformed for 
conventional MRI contrast agents, the micro-scale particles may be of optimal size for in 
vivo cell tracking applications in which a group or several different groups of cells are 
labeled with one or more types of contrast agent and their locations and potentially, their 
functionality, are tracked by MRI. This application is useful for experiments aimed at 
providing insights into in vivo cell biology using MRI, such as monitoring the migration 
of labeled cells in certain therapeutic applications. There is growing interest in in vivo 
cell tracking capability with the growing potential of cellular therapeutics such as the use 
of stem cells (Bulte et al. , 1999; Graham et al. , 2010; Hill et al. , 2003; Hoehn et al. , 
2002). Micro-scale particles may have a distinct advantage over nano-scale particles as 
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the numbers of particles needed to label a cell for imaging are significantly reduced and, 
in fact, imaging of single cells labeled with single particles is possible (Shapiro, Skliic, & 
Koretsky, 2005). In addition, given the potential for multiplexed imaging, several groups 
of cells might be monitored simultaneously, amplifying the complexity of biomedical 
questions which may be answered using MRI. Other applications for cellular imaging 
include the evaluation of immune cell therapies for potential therapeutic effects against 
various tumors or cell-based tissue engineering applications (Ladhams et al. , 2002; L. 
Muller, Provenzani, Faul, & Pawelec, 2001 ; Saldanha, Doan, Ainslie, Desai, & 
Majumdar, 2011). 
[Figure 3-24: Amyloid plaques labeled with iron oxide nanopmiicles seen as hypointense 
foci (B) on MRI.] 
In the case of the nano-scale pmiicles, tm·geted in vivo molecular imaging 
becomes feasible, where molecularly targeted contrast agents would overcome existing 
limitations and offer myriad potential applications. For systemic delivery, the upper limit 
of size is imposed by the limitation in transendothelial passage and tissue penetration as 
well as rapid clearance by the reticuloendothelial system (RES) and the mononuclear 
phagocytic system (MPS) through the liver, spleen, and bone mmTow (Alexis, Pridgen, 
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Molnar, & Farokhzad, 2008). Currently available iron oxide nanoparticles (SPIO, USPIO) 
have been applied to a wide array of molecular imaging applications. For example, 
monoclonal antibody linked or peptide conjugated nanoparticulate iron oxide particles 
have been utilized for various molecular imaging approaches ranging from the detection 
of myocardial infarction (Weissleder, Lee, Khaw, Sherr, & Brady, 1992), imaging lung 
and pancreatic carcinomas (Remsen et al., 1996; T. T. Sherr et al., 1996), tumor apoptosis 
imaging (Zhao, Beauregard, Loizou, Davletov, & Brindle, 2001), and imaging beta-
amyloid plaques in the brain in Alzheimer's disease (Wadghiri et al., 2003) (Figure 3-
24). Again, current nanoparticulate agents lack functional capability and offer only the 
potential of localizing a given target while the top-down fabricated nano-scale agents will 
also derive functional capability from their precise geometry, thereby offering functional 
capacity in molecular imaging using MRI. In addition, direct targeting of various 
components of a tumor or atherosclerotic plaque becomes conceivable, given the 
potential for multiplexed imaging. 
3.5.3 Scalable Manufacturing 
Lastly, an important consideration in fabricating MRI contrast agents in a top-
down fashion, as is reported herein, is the capacity to scale the fabrication processes to 
industrially and economically appropriate levels. In the case of the micro-scale particle 
arrays in both double-disk and hollow-cylinder configurations, as the fabrication 
approaches employed conventional photolithography and micromachining techniques, it 
is conceivable to be scaled and is relatively cost-efficient. However, in the case of the 
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nano-scale fabrication approach, given the use of electron beam lithography, the capacity 
to scale this approach while remaining cost efficient is more difficult to achieve. 
Neve1iheless, the reported approach serves as a proof of concept validation of the use of 
RF reactive sputtering and ion milling, in combination with a fabricated nanohole array, 
to yield precisely fabricated nano-scale hollow cylinders. 
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[Figure 3-25: (A) Combine AAO membrane and ALD for magnetic nanotube fabrication. 
(B-E) Transmission electron micrographs (TEM) of 200 run (B, C) and 60 nm (D, E) 
diameter silica nanotubes without magnetite (B, D), and magnetic nanotubes (MNTs) 
with magnetite (C, E).] 
Furthermore, the nano-scale approach may be readily modified to include a more 
cost efficient and technically scalable approach to fabricate the nanohole arrays such as 
imprint lithography (as described in Chapter 4), which provides a parallel processing 
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nature, m contradistinction to the strictly serial nature of electron beam lithography 
(Chou, Krauss, & Renstrom, 1996). As shown in Figure 3-25, combining a nanoporous 
anodized aluminum oxide (AAO) template with atomic layer deposition (ALD), magnetic 
nanotubes was synthesized and were demonstrated for their magnetic-field-assisted 
chemical and biochemical separations, immunobinding, and drug delivery. (Son, Reichel, 
He, Schuchman, & Lee, 2005). This method could be considered for synthesizing the 
hollow-cylinder nanoparticles at a much larger scale compared to the EBL-based 
fabrication reported herein. 
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CHAPTER4 
CT CONTRAST AGENTS 
As previously discussed, by simply increasing the size of the CT contrast agents 
from macromolecules (iodinated organic compounds, less than 1 nm) to nanoparticles 
(ranges from several nanometers to tens or hundreds of nanometers), the vascular 
circulation time can be increased by orders of magnitude. In addition, filament-shaped 
(Geng et al., 2007) or rod-shaped (Champion & Mitragotri, 2006) particles can also 
increase circulation times to up to a week, as well as impact the cellular uptake behaviors 
and pharmacokinetics. As a major limitation mentioned in section 2.3, it is of great 
benefit to fabricate the nanoparticles with precisely controlled size, shape, and surface 
properties etc., cost-effectively, in order to further study the interaction between the 
nanoparticles and the biological system (nano-bio interactions) (Albanese et al., 2012). 
In this chapter, a nanomanufacturing platform will be proposed and developed to 
offer an alternative solution to a low-cost, high-throughput fabrication of size and shape 
specific polymeric nanorods. 
4.1 Nanomanufacturing Platform 
4.1.1 Design Rationale 
The concept of the nanomanufacturing platform proposed herein is rather simple: 
sacrificing a certain degree of freedom in the control of particle shape in order to make 
the process cheaper, less time-consuming, and more accessible and scalable compared to 
87 
other nanofabrication methods introduced in section 2.3 .2. 
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[Figure 4-1: Process flow concept of the combined imprint and lithography 
nanomanufacturing platform for size and shape specific polymeric nanorods.] 
As shown in Figure 4-1 (A-B), anodized aluminum oxide (or anodic aluminum 
oxide, AAO), which represents a self-ordered nanoporous material, will be employed to 
direct the precise fabrication of imprint lithography molds for subsequent polymeric 
nanorod production. AAO is prepared by the electrochemical oxidation of aluminum 
films, and has been extensively employed to assist in the fabrication of various 
nanostructured materials that have found wide applications in a variety of areas from the 
development of electronic and magnetic devices to next generation energy storage, 
among others (Banerjee, Perez, Hem1-Lecordier, Lee, & Rubloff, 2009; Jin et al., 2008). 
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In biomedicine, AAO templates have been used in the development of diagnostic devices 
employing surface enhanced Raman scattering (SERS), biomedical sensing systems, and 
advanced cell culture techniques, among a host of other wide ranging applications 
(Cheng et al., 2012; Kumeria, Parkinson, & Losic, 2011; G.-J. Wang et al., 2009). The 
titanium (Ti) serves as an adhesion promoting layer between the AAO and the substrate, 
as well as blocking the UV light selectively so that the flash layer connecting each 
particles could be eliminated during UV imprinting. 
While the optimal size and shape of the nanorods likely depends on the particular 
clinical application, the nanomanufacturing platform proposed herein readily 
accommodates the fabrication of hydrogel nanorods in the size regime reported to 
achieve passive targeting, long vascular circulation, and high degrees of intracellular 
uptake. In addition, it is inherently suited to fabricate rod (and filament) shaped 
polymeric nanoparticles, a shape which offers several advantages for the intended 
purpose of drug/contrast agent delivery, as described in 2.3 .1. 
Payloads of X-ray attenuating materials can be incorporated with hydrogel-based 
nanoparticles to yield next generation CT contrast agents of precisely tunable size, shape, 
and elasticity. Compared to conventional CT contrast agents, they have several 
fundamental advantages: (1) As the critical parameter in CT is the delivery of an 
appropriate amount of X-ray attenuating material per voxel, the ability to encapsulate 
large amounts of an iodinated contrast agent or tantalum . oxide nanoparticles in a 
hydrogel vehicle confers the potential to utilize CT to image specific targets (Cormode et 
al., 2010; J. Li et al., 2010; Popovtzer et al., 2008). (2) The ability to encapsulate 
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multiple X-ray attenuating payloads also enables the capacity for multiplexed imaging 
using CT. With differences in their X-ray absorption spectra under various X-ray beam 
energies, material decomposition can be achieved using multispectral CT in which 
several energies of X-ray beams are emitted simultaneously (Cormode et al. , 2010). (3) 
Furthermore, an in vivo biological sensor can be realized by using environmentally 
responsive hydrogels (pH, temperature, or enzyme sensitive hydrogels) for functional CT 
imaging. For example, a peptide crosslinked hydrogel for protease sensing has been 
developed to monitor protease activity in vivo, which can be degraded in the presence of 
certain cell-secreted enzymes, indicating possible inflammation or malignancies 
(Glangchai et al. , 2008; Levesque & Shoichet, 2007). Upon degradation, X-ray 
attenuating payloads will be released and rapidly diffused/cleared out of the target area, 
resulting in decreased contrast from CT images. 
4.1.2 Background 
It is desired for the AAO membrane to have a highly ordered nanoporous 
geometry, though realizing a perfectly ordered array remains technically challenging. The 
majority of approaches to fabricating ordered nanoporous arrays prepare highly ordered 
' 
AAO membranes on bulk aluminum foils using a two-step anodization process (A.-P. Li, 
Muller, Birner, Nielsch, & Gosele, 1999; Masuda & Fukuda, 1995). However, as is the 
case with this proposed platform, many fabrication processes demand the integration of 
highly ordered AAO with underlying substrates such as silicon or quartz (Zhang, Shimizu, 
Senz, & Gosele, 2009). To this end, one approach which has been reported employs 
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aluminum (Al) foils to synthesize the highly ordered AAO membranes followed by 
physical transfer and attachment of the nanoporous membranes to the substrate of interest 
(lung, Jung, Gu, & Suh, 2006; Zhang et al. , 2009). An alternative approach to physical 
transfer of the AAO films initially fabricated on Al foils, the fabrication of nanoporous 
AAO anays directly on a substrate of interest following the deposition of Al thin films, 
offers a highly efficient process methodology but introduces added technical challenges. 
The technical difficulties in fabricating highly ordered anodic aluminum templates 
directly on a substrate include the difficulty of depositing a sufficiently thick aluminum 
film for the subsequent anodization steps as well as the challenge of completely 
eliminating the batTier layer produced during aluminum anodization (Jung et al. , 2006). 
Nevertheless, a two-step anodization of Al thin films has been successfully employed in 
the fabrication of well-ordered nanoporous AAO anays on silicon substrates (Ta~altm, 
Oztiirk, Kllm<;, Ylizer, & Oztiirk, 2009), as shown in Figure 4-2. 
[Figure 4-2: SEM images of the fabricated AAO template, (A) top view, and (B) cross-
sectional view.] 
In order to further improve the ordering of the geometry of nanopores formed in 
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the AAO templates, a host of pre-patterning techniques have been employed, using both 
bulk Al foils as well as Al thin films deposited directly on underlying substrates (B. Kim, 
Park, McCarthy, & Russell, 2007; Kustandi, Loh, Gao, & Low, 2010; Maria Chong, Tan, 
Deng, & Gao, 2007) (Figure 4-3). While these pre-patterning techniques inherently 
decrease the overall efficiency and increase the cost of the fabrication processes, they 
yield the potential to create near-perfect arrays of nanoporous AAO. Recently, a step and 
flash imprint lithography (S-FIL)-based approach has been reported which has the 
capacity to be efficiently employed in the pre-patterning of Al thin films on substrates to 
fabricate near-perfect AAO arrays on a wafer scale (Kustandi et al. , 2010) . 
[Figure 4-3: SEM images of near-perfect ordered AAO nanopores: (A) sample made 
from prepatterned AI; (B) higher magnification of (A) with clear distinction between 
prepatterned (left) and non-patterned (right) AAO pore anangement; (C) honeycomb-like 
structure made from prepatterned Al; (D, E) samples made from prepatterned Al; (F) 
sample made from thicker pre patterned Al films (1 11m).] 
For more details on the mechanism of AAO formation and various aspects of this 
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widely utilized process in industry, please refer to the dissertation by Dr. Choi (J. Choi, 
2004). 
4.2 Micro-scale particles 
To demonstrate the feasibility of the proposed method, proof-of-concept 
experiments were first demonstrated at micro-scale using several fabrication methods, 
including the nanomanufacturing platform previously proposed. Some results presented 
in this section were published in Journal of Vacuum Science & Technology B (C. Wang, 
Wang, Zhang, & Anderson, 2014), and the Proceedings ofTransducers 2013 (X. Wang, 
C. Wang, S. Anderson, & X. Zhang, 2013). 
4.2.1 Fabrication 
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[Figure 4-4: Micro-scale hydrogel particle fabrication process flow with combined 
photolithography and imprint technique. (A, B) Mold fabrication; (C, D) Hydrogel 
precursor drop coating, and UV imprint; (E-G) Peel off the substrate with polymerized 
hydrogel particles, un-crosslinked hydrogel precursor can be washed away.] 
To demonstrate the combined photolithography and imprint molding method to 
eliminate the formation of the flash layer usually found in other imprint-based hydrogel 
fabrication techniques, a micro-scale fabrication process is shown in Figure 4-4. A UV-
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blocking chromium (Cr) layer (~150 nm) was first patterned on top of a UV-
transmissible quartz substrate by lift-off, followed by RIE etching of quartz to form the 
mold with the Cr layer as the etching mask. 
Photo-polymerization of hydrogel precursors can only occur within the Cr/quartz 
hybrid mold, thereby forming hydrogel particles without the need for a subsequent 
oxygen plasma etching to remove the flash layer, as shown in Figure 4-5. The hydrogel 
precursor solution contains PEG-DA (average Mn 575, Sigma-Aldrich, MO), 
crosslink:ing agent (photoinitiator, 2-hydroxy-2-methylpropiophenone, Sigma-Aldrich, 
MO), deionized water (DI) water, as well as X-ray attenuating materials. The elastic 
property of the hydrogel particles after crosslinking can readily be adjusted by changing 
the content ratios between these components, as well as crosslinking conditions. 
[Figure 4-5: SEM images of fabricated hydrogel disks ( ~ 10 !!ill diameter, ~ 1 !!ill 
thickness) with no flash layer formation. Scale bars are 10 11-m and 50 11-m.] 
The fabrication process yielding composite hydrogel microparticles for CT 
imaging is shown in Figure 4-6. The hydrogel precursors were comprised of PEG-DA, 
an X-ray attenuating payload, DI water, and a photoinitiator. Specifically, 45% PEG-DA 
(v/v), 5% DI water, and 50% 10 nm gold nanoparticle solution (Ted Pella, Inc. , CA, 
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USA), as well as an additional 1.5% photoinitiator were drop-coated onto silicon wafers. 
Subsequently, a transparent polyethylene terephthalate (PET) film was placed on the 
hydrogel precursor layer in order to serve as a supporting substrate for hydrogel pmi icles. 
Next, the precursors were exposed to UV light (Karl-Suss MA6, SUSS MicroTec, CA) 
for 60 seconds at 10 m W/cm2 through a photomask to yield polymerization of the 
hydrogels. Finally, the PET film with the adherent hydrogel pattern was separated from 
silicon substrate, readily accomplished by peeling this support layer from the underlying 
silicon substrate. Finally, a surgical blade was employed to mechanically remove the 
composite hydrogel pmiicles from PET film and the individual pmiicles were harvested. 
(A) 
(C) 
(B) 
Substrate ~ Photomask - UV Light 
D PET Film Hydrogel with Payloads 
[Figure 4-6: Microfabrication process flow for composite hydrogel particles. (A) 
Hydrogel precursors containing X-ray attenuating media are initially drop-coated onto an 
underlying silicon substrate; (B) A PET film is placed onto the hydrogel precursor layer; 
(C) The polymer precursor is exposed to UV light through a photomask; (D) Peel the 
PET film off the substrate, along with the hydrogel microparticles.] 
The same photolithography approach was employed to fabricate hydrogel 
particles with an iodine based conventional CT contrast agent. To this end, the following 
composition was employed: 18% PEG-DA (v/v), 72% DI water, and 10% of iopamidol-
95 
370 (Isovue-370, Bracco Diagnostic, Inc. , NJ, USA), as well as the aforementioned 
photoinitiator. 
[Figure 4-7: Hydrogel micropm1icle arrays m·e demonstrated on the underlying PET film 
after peeling of the polymeric film from the original silicon substrate.] 
Figure 4-7 demonstrates arrays of fabricated hydrogel rnicroparticles on a flexible, 
underlying PET film after peeling off the silicon substrate. Figure 4-8 demonstrates 
several iodinated hydrogel rnicroparticle arrays with different shapes and sizes fabricated 
using the photolithography approach employed here. Furthermore, it also illustrates 
composite hydrogel particles harvested from the PET film. 
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[Figure 4-8: (A-C) SEM images of composite hydrogel microparticle arrays of varying 
sizes and shapes. (D) Optical microscopy image of composite hydrogel microparticles 
after being harvested from the PET film. Scale bars are 1 00 11m.] 
As revealed in Figure 4-7 and Figure 4-8, the fabrication approach delineated 
herein may be applied to fabricate particles ranging from 2 to 3 11m to tens of microns or 
more . Of note, while the larger particles were readily removed from their underlying 
substrate using mechanical removal with a surgical blade, optimizing the efficiency of 
removal of smaller, micro-scale particles may require alternative approaches. 
Nanoindentation and rheology measurements were employed to characterize the 
mechanical properties of bulk PEG-DA hydrogels with varying concentrations and 
degrees of crosslinking. Results were published in Journal of Vacuum Science & 
Technology B (C. Wang, Wang, Zhang, et al., 2014). 
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4.2.2 CT imaging 
For purposes of the stability experiments, hydro gels composed of both 50% and 
80% PEG-DA (v/v) were employed (along with 1.5% photoinitiator). The payloads 
included 5% iopamidol-370 (v/v) as well as a 0.5% Au nanoparticle solution (v/v). UV 
exposure times of both 30 and 80 seconds were employed to generate varying hydrogels. 
A clinical 64 multi-detector CT (MDCT) scanner (Light-Speed VCT; GE Medical 
Systems, Milwaukee, WI) was employed in the leakage rate measurements. Hydrogels 
containing X-ray attenuating payloads were submerged in DI water and CT images were 
acquir~d sequentially over time (from immediately after submerge in water to 66 hours 
after that) . Pertinent CT scan parameters were as follows: 0.625 rnm slice thickness, 120 
kVp, and 700 mAs. Attenuation values of the hydrogels were recorded over time using 
region of interest (ROI) measurements. 
Table 4-1: Normalized attenuation (HU) over time of X-ray attenuating payload bearing 
hydrogel samples as a function of varying PEG-DA concentration and UV exposure time 
Sample Time After Submerge in Water 
PEG-OA UV Exposure 
Initial 
2 15 18 66 
Payload 2 Hours 
Concentration Time Minutes Minutes Hours Hours 
Iodine5% 50% 30 1 1 1 1 0.69 0.21 
Iodine 5% 80% 30 1 1 1 1 0.83 0.78 
Iodine 5% 80% 80 1 1 1 0.94 0.78 0.74 
GNPO.S% 50% 30 1 1 1 0.57 0.57 0.36 
GNPO.S% 80% 30 1 1 l 1. 1 1 
GNP 0.5% 80% 80 1 1 1 1 1 1 
Measurements of the stability of the composite hydro gels containing varying X-
ray attenuating payloads revealed variations in stability as a function of hydrogel 
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composition, UV exposure time, as well as payload composition are listed in Table 4-1. 
None of the payloads were seen to leak from any of the hydrogels within 15 minutes of 
immersion in water, which is appropriate for most imaging timeframes. Starting from the 
2 hour timepoint, leakage could be identified which was most marked in the case of the 
gold nanoparticle bearing hydrogels. At the 18 and 66 hour timepoints, more significant 
leakage was identified, most marked in all of the iodine and gold nanopmiicle payloads 
with 50% PEG-DA (Figure 4-9). 
[Figure 4-9: CT images of iodine containing hydrogel (50% PEG-DA, 30 seconds UV 
exposure) demonstrate leakage of the X-ray attenuating payload with a nearly 80% 
decrease in HU over a period of 66 hours. (A) 2 minutes after addition of water to 
hydrogel samples; (B) 66 hours after addition of water to hydrogel samples.] 
For both iodine and gold, more significant leakage was seen in the 50% PEG-DA 
samples, with the degree of leakage also influenced by UV exposure times, possibly 
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reflecting a "looser" network of polymer chains given the lesser concentration of PEG-
DA and shorter UV exposure. 
Next, fabricated composite hydrogel structures were produced with both iodine 
and gold as the X-ray attenuating payload for purposes of subjectively evaluating the CT 
attenuating propetiies of the fabricated microstructures. In this case, hydrogel 
microstructures with 33% iopamidol volume concentration (as well as 45% PEG-DA, 
22% DI water, and the photoinitiator) as well as samples with 10 mg/ml gold 
nanoparticles (as well as 65% PEG-DA, 30% DI water, and the photoinitiator) were 
tested in a microCT scanner (!-LCT -40, Scanco Medical, Switzerland). 
[Figure 4-10: Three-dimensional volume rendered CT images demonstrate high X-ray 
attenuation of the composite hydrogel structures with (A) iodinated and (B) gold 
nanoparticle payloads.] 
The CT images of the composite hydrogel micro-structures are shown in Figure 
4-10 (structured in the shape of letters "BMC CT"). These images demonstrate a high X-
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ray attenuation of the fabricated hydrogel structures for both iodinated (iopamidol-370) 
and gold nanoparticle payloads. 
4.3 Nanoscale Mold Fabrication 
To achieve highly uniform nanoporous AAO membranes that are directly grown 
on silicon/quartz substrates, while maintaining process scalability and relative simplicity, 
a novel three-step anodization technique is developed herein, as shown in Figure 4-11 . 
Aluminum .. Titanium 
(F) ;•.·.·~·.·.·.-.-.•.•.• ••• , •••••••• ' 
................ ri'.•.W:•.•.-.·rl'······ 
·~·-·~·=·=-=·=·~=·!·~=-~·=·=·=·~·=·' 
••••••••••• (G) : ~ •s••: --~ ~-. ~ .•~ ~·. ~. ·=' .. •w• 
······""· ......... ······· ......... ' 
........ _._._ .... •-•.M• .. •-·-·-·-·-·-·-·-· ·-· 
PAA Release Layer 
A d. d AI . .. ... _. .••••• s·1· /Q S t t no 1ze umma :~ .. ~.:·~·:. 1 1con uartz us ra e 
[Figure 4-11: Nanoporous mold fabrication process flow. (A) Ti and sequential 
segmented aluminum deposition. (B-F) Three-step aluminum anodization. (G) RIE patter 
transfer.] 
Each of these steps will be explained in further detail below. 
4.3.1 Thin Film Deposition 
A thin Ti layer and a thick Allayer were sequentially deposited onto the substrate 
using a e-beam evaporator (Solution Process Development System, CHA Industries, CA) 
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after standard wafer cleaning (Figure 4-11 , step A). Ti not only serves as the UV-
blocking layer but more importantly, it significantly improves the adhesion between the 
substrate and anodized alumina layer. 
[Figure 4-12: SEM images of the surface of the aluminum layer after e-beam 
evaporation.] 
As mentioned previously, the uniformity and self-ordering of the AAO is directly 
related to the duration of anodization and the Al film quality. The longer the anodization 
time of each step and the better film quality, the more uniform and well-structured the 
resulting AAO film. Therefore, to improve mliformity during anodization, while 
balancing processing time and complexity, a segmented deposition approach was 
developed for the Al evaporation process. Specifically, the first ~ 100 nm of Al layer was 
deposited at low deposition rate ( ~ 1 Als ), followed by a thick layer (thickness varies) 
deposited at ~15 Als, and a final ~100 nm layer deposited at ~ 1 Als. The first slow rate 
deposition serves the purpose of ensuring good adhesion between Ti and Al. The second 
fast rate deposition achieves a relatively large thickness layer within a reasonable amount 
of time, while the last slow deposition is crucial for obtaining good Al film quality for the 
initial stage of the anodization. As can be seen from the SEM images in Figure 4-12, 
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pristine Al film was deposited with clear grain boundaries. Larger grain size also helps to 
improve uniformity after anodization. Compared to Al films deposited at a fast rate only 
(without the final slow rate deposition), as shown in Figure 4-13, more surface defects 
were observed (black areas on SEM images) with no obvious grain boundary, which 
resulted in inferior AAO membrane (see 4.5.1). 
[Figure 4-13: SEM images of the surface of the aluminum layer using only fast rate 
deposition, showing no obvious grain boundary, and more surface defects.] 
In practice, the thickness of the Ti layer should be approximately 150 nm, in order 
to ensure sufficient UV -blocking but at the same time not too thick for RIE pattern 
transfer. The thickness of the Al, on the other hand, can be varied and depends on the 
subsequent anodization parameters. The final thickness of the AAO is determined by 
both the initial Al thickness, as well as the anodization parameters and durations of each 
stage. As shown in Figure 4-14, cross-sectional SEM images of the deposited Ti and Al 
on a Si substrate, with both layers clearly visible. 
In the particular case of Figure 4-14, the thickness of Ti and Al are ~ 150 nm and 
~4.8 !lm, respectively, which is one of the thickest Allayer deposited in this dissertation. 
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[Figure 4-14: SEM images of the cross-section of the aluminum layer after e-beam 
evaporation. (A) ~ 70° tilt angle. (B) 90° tilt angle.] 
4.3.2 Aluminum Anodization 
Voltage-control 1 1JmA 1 
Power Supply~ 
Temperature 
Control 
Refridge 
Circulator 
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t!J 
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[Figure 4-15: Experimental setup for aluminum anodization.] 
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The experimental setup for the anodization process is shown in Figure 4-15, 
which mainly consists of a refrigerated circulator (RTE-211, NESLAB, Thermo 
Scientific, MA) to provide cooling water bath for the electrochemical · reaction, a 
magnetic stirrer for mixing the chemical solution, a voltage-control power supply to 
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maintain a constant voltage output during anodization, and a digital multimeter for 
recording the cunent change overtime. Both the refrigerated circulator and the magnetic 
stiner are in place to help dissipate the heat generated at the surface of the anodized 
alumina layer. 
Anodization is carried out in 0.3 molar [M] * oxalic acid (22.69 g oxalic acid 
dihydrate in 600 mL DI water) solution at 1 °C, with a constant voltage applied between 
the aluminum thin film anode and a stainless steel rod cathode. The aluminum sample 
was mounted on a piece of poly( methyl acrylate) (PMA) plastic slab using conductive 
copper tape to provide electrical connection to the power supply. All exposed copper tape 
was subsequently covered using chemical resistant tape to prevent it from reacting with 
the oxalic acid (Figure 4-16). 
Conductive copper tape Chemical-resistant PMMA tape 
Chemical resistant PMA slab Sample wafer with AI film 
[Figure 4-16: A sketch showing how the sample wafer should be mounted for the 
anodization process.] 
The process of aluminum anodization can be affected by many variables: the 
type of electrolyte, the concentration of electrolyte (pH) , solution temperature, and 
* 1 molar, or I M, represents 1 mol/L. 
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voltage, etc. , for which the type of electrolyte and anodization voltage are the most 
impmiant. Depending on the voltage applied and the specific electrolyte, the self-
ordering of nanoporous AAO membrane can be achieved with a range of inter-pore 
spacings, as plotted in Figure 4-17 (A. P. Li, Muller, Birner, Nielsch, & Gosele, 1998). 
-
500 
E 
c 
-Q) 375 (.) 
c 
ctS 
..... 
en 250 0 
Q) 
.... 
0 125 c.. 
I 
.... 
Q) 
.... 
c 
0 
0 
... 
...... 
•• 
45 90 
• 
• 
• 
• Sulfuric Acid 
T Oxalic Acid 
• 
• Phosphoric Acid 
135 
Anodic Voltage (V) 
180 
[Figure 4-17: Inter-pore distance as a function of the applied anodization voltage for 
various electrolyte.] 
Sulfuric acid based anodization yields inter-pore spacing on the order of tens of 
nanometers, which is too small for the desired size range of the polymer nanorods for 
contrast agent delivery purposes. Phosphoric acid (H3P04) based anodization, on the 
other hand, due to the high voltage required, needs a conesponding high current output 
(peak amperage over 3 A) from the power supply. The anodization rate, or the thinning 
rate of Al, is also significantly faster when increasing the anodization voltage above 110 
V. Experiments found that an approximately 3 J..Lm thick Al film was anodized under only 
5 minutes, whereas the typical Al thinning rate that will be discussed below is usually 
around 20~30 nm/minutes. This results in the fact that the process is extremely difficult 
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to control. Therefore, for this study, -0.3 M oxalic acid (C2H204) is chosen as the 
electrolyte, and the voltage was fine-tuned between 40 V to 60 V to fmd the optimal 
parameter. 
[Figure 4-18: SEM images of the Al sample after the first anodization. (A) Top view 
showing small ( ~20 nm 0) pores forming throughout the anodized surface. (B) Cross-
sectional view showing the gradually more ordered nanopore formation.] 
[Figure 4-19: Zoomed in view of the divots formed at the interface between AAO and 
Al.] 
As shown in Figure 4-18 and Figure 4-19, the first anodization will transform 
approximately one third of the thickness of Al into AAO. Depending on the desired final 
AAO thickness, as well as the initial Al film thickness, the anodization time of this first 
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stage can take from 15 to 40 minutes at an A1 thinning rate of 20~30 run/min 
(corresponding to 40~50 V anodization voltage). Because the oxygen atoms have been 
introduced to the original A1 matrix, the volume expansion causes the AAO thickness to 
be roughly 1.4 times more than the thickness of consumed Al, which agrees well with the 
data from literature (A. P. Li et al. , 1998). After thoroughly rinsing off the oxalic acid 
residue, the sample is transferred to a 5 wt.% H3P04 bath (31.25 g 85 wt.% H3P04 in 500 
mL DI water), and etched for 60 minutes at 30 octo remove the first AAO layer, as seen 
in Figure 4-20. 
[Figure 4-20: SEM images after the first AAO removal. (A) Top view showing ~ 100 nm 
0 divots on aluminum surface developed from the pressing force during AAO formation. 
(B) Cross-sectional view.] 
Under the same conditions, a second anodization followed by AAO removal is 
performed. At this point, the honeycomb structure is clearer, and both the uniformity and 
defects are improved as well (see Figure 4-21). With the hexagonal honeycomb structure 
more well-defined, pores are more likely to start forming at the center of each of the 
divots, rather than at random locations where there were ce1iain surface defects, as shown 
in Figure 4-18. 
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[Figure 4-21: (A, B) SEM images after the second anodization, top view (A) showed 
more organized pore distribution within each hexagon, and cross-sectional view (B) 
revealed more straightened pore structures. (C, D) SEM images after the second AAO 
remove, top view (C) showed clear distribution of hexagonal shaped honeycomb 
structure. *Note: Remaining AAO residue in (C) due to insufficient H3P04 etching.] 
The third and final anodization step will transform all of what is left of the 
aluminum film, and the pores will reach the titanium layer with a barrier layer in between. 
Afterwards, H3P04 will be used again to etch the AAO to widen the pores to the desired 
diameter, without completely removing them, the duration of which is usually less than 
30 minutes such that the walls between the pores are not too thin. SEM images are shown 
in Figure 4-22. 
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[Figure 4-22: (A, B) SEM images after the third anodization, top view (A) showed more 
well-organized pore distribution with one pore formed in each hexagon, and cross-
sectional view (B) revealed straight pore structures. (C, D) SEM images after widening 
the pores in H3P04, top view (C) showed uniformly distributed nanoporous AAO 
membrane, and the barrier layer between the AAO and Ti layer is clear visible in the 
cross-sectional view (D).] 
The above series of SEM images at different stages of the 3-step anodization 
process only serves as an example to demonstrate each step. A range of nanopore 
diameter and spacing can be achieved by controlling the anodization voltage and 
electrolyte type and concentration. For example, anodized using 10 wt.% H3P04 under 
110 V will yield significantly larger pores, as shown in Figure 4-23, which is obviously 
useful for controlling the final size and shape of the nanorods. 
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[Figure 4-23: (A) Anodized using C2H204 at 50 V yields ~90 nm 0 pores with ~ 100 nm 
inter-pore distance; (B) Anodized using H3P04 at 110 V yields ~ 180 nm 0 pores with 
~200 nm inter-pore spacing.] · 
Wafer-level uniform AAO membranes were successfully fabricated on both 
silicon and quartz substrates with excellent adhesion (Figure 4-24 A and B, respectively). 
The size of the samples are only limited by the experimental setup, as the beaker 
containing the chemical solution can only accommodate a 2-inch wafer. It would be 
relatively easy to scale this process up to much larger wafers. 
-smm 
[Figure 4-24: (A) Silicon substrate. (B) Quartz substrate. (C) AAO membrane peeled off 
due to insufficient adhesion.] 
Several different metals other than Ti were also tested as the UV-
blocking/adhesion-promoting layer, such as chromium, gold, and platinum, none of 
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which provided sufficient adhesion as titanium, so that the AAO membrane would buckle 
up and peel off the substrate during or after the anodization process, as shown in Figure 
4-24 C. The same delamination of the AAO after anodization also happened without the 
Ti layer, with Allayer directly deposited on the substrate. 
4.3 .3 Pattern Transfer 
Reactive ion etching was used to transfer the nanoporous patterns of the AAO 
membrane to the underlying Ti layer and substrate. Three stages of etching need to be 
achieved: (1) alumina barrier layer, (2) titanium layer, and (3) silicon/quartz substrate, as 
illustrated in Figure 4-25. 
Barrier Layer 
Nanoporous AAO Titanium Si/Quartz Substrate 
[Figure 4-25: Illustration of the three types of materials that need to be etched during 
RIE in order to successfully transfer the nanoporous pattern.] 
Gases available to the RIE system (790 Series, Plasma-Therm, FL) include 
hydrogen (H2), helium (He), nitrogen (N2), oxygen (02), chlorine (Cb), argon (Ar), 
trifluoromethane (fluoroform, CHF3), tetrafluoromethane (CF4), bromotrifluoromethane 
(CBrF3), and sulfur hexafluoride (SF6). Of the three main reactive species, 0, F, and Cl, 
0-based gases are mostly for polymer based materials, F- and Cl-based gases can be used 
to etch most of materials. In this particular case, these reaction mechanisms need to be 
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considered: 
AI+ 3Cr ~ AlCl3 t 
Ti+4Cr ~TiCl4 t. 
Si + 4Cr ~ SiCl4 t 
AI+ 3F-~AlE; 
Ti+4F-~Ti~ t 
Si+4F- ~Si~ t 
Eq. 4-1 
Eq. 4-2 
Based on the vapor pressure of the reaction byproduct, AlCb is much more 
volatile than AlF3 *, therefore it is much easier to escape from the sample surface. After 
some optimization experiments, the gas mixture used for this etching process was 
determined to be 32 seem Cb, 10 seem Ar, and 8 seem Hz. To enhance anisotropic 
etching, as well as increase etching rate, the chamber pressure was kept at ~50 mTon, 
and RF power was set between 300~400 W depends on what etching rate was desired. 
Because both Cb and F-based gases are used in the same RIE system, instead of 
being used separately, RIE results tend to vary if the chamber was not properly cleaned 
and conditioned prior to running the process. In general, however, using the 
aforementioned parameters will yield etching rates of anodized alumina, titanium and 
quartz at roughly ~ 10 nm/minutes, ~20 nm/minutes, and ~30 nm/minutes, respectively. 
As shown in Figure 4-26, several SEM images were taken for different samples at 
varying etching times and RF power. A range of aspect ratios and etching profiles was 
achieved. 
* The boiling point at 1 ATM for AJCJ3 is 177.8 °C, and for AIF3 is 1291 °C (Cheung, 2010). 
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[Figure 4-26: Several SEM images of different pattern transfer results using different 
RIE parameters.] 
The AAO layer that was still left on the sample was removed using 0.1 M NaOH 
for 30 minutes in an ultrasound bath, leaving only patterned Ti and substrate as the hybrid 
mold for the subsequent the1mal or UV imprint process. Due to multiple SEM inspections 
of the cross-section up to this point, all the mold samples were smaller pieces split from 
the original wafer, as shown in Figure 4-27. 
114 
-1cmllliliiiillliiilillillili•-- ---_J 
[Figure 4-27: (A-C) SEM images of the mold surface after removing the AAO layer. (D) 
Nanoporous quartz mold with titanium mask. *Note : The pore size appears to be not 
uniform in (B), which is due to the cutting angle when making the cross section. The non-
transparent areas in (D) are titanium layers without nanoporous patterns, the Ti layer on 
the active imprint area appears completely transparent.] 
4.4 N anoimprinting 
As shown in Figure 4-28, nanoimprinting using the fabricated hybrid mold 
involves the following steps: (A) Sequentially spin-coating polyacrylic acid (P AA, 
sodium salt, 60K Mw, Polysciences, P A) layer, and the polymer precursor; (B) 
Imprinting while introducing heat and/or UV light to induce crosslinking; (C) De-mold 
the nanorods from the mold, and wash away the unexposed region (UV imprint only); (D) 
Dissolve the P AA layer by switching its water solubility and therefore releasing the 
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nanorods. 
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[Figure 4-28: Process flow ofnanoimprinting using the nanoporous hybrid mold.] 
4.4.1 Mold Surface Treatment 
The patterned hybrid mold can be used for imprinting both thermoplastic and 
photopolymerizable polymers. To ensure smooth de-molding, where no polymer would 
remain stuck inside the molds, a super-hydrophobic surface treatment on the mold is 
necessary. The steps for the surface treatment of the mold are as follows: 
(1) Clean the mold surface in acetone ultrasonic bath for at least 5 minutes, then 
switch to IP A ultrasonic bath for at least 5 minutes; 
(2) 02 plasma asher for at least 10 minutes with 300 seem flow rate and 300 W 
power; 
(3) Mixing mold release agents NXT-110A and NXT-llOB (A:B = 1:2 ratio 
approximately, either by volume or by weight) in a clean and completely dried glass 
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beaker, and gently shake or stir for ~20 seconds (NXT -11 OA and NXT -11 OB are 
proprietary chemicals purchased from Nanonex, NJ); 
(4) Bake the cleaned mold on a hotplate at 70 oc for 1 minute. While still warm, 
immerse the mold into the mixture solution from (3). Soak while agitate for 1 minute, 
then soak for 2 minutes with acetone (or methanol, or NXT-110B); 
(5) Blow dry the mold using a nitrogen gun, then bake on the hotplate at 90 oc for 
3 minutes (or vacuum oven at 80 oc for 10 minutes). 
After the surface treatment, the mold will become super-hydrophobic, i.e. with 
reduced surface energy. The water contact angle was not measured, but should be much 
larger than 90°, where a drop of water should slide off the surface with the mold surface 
tilted. The subsequent nanoimprinting process is very sensitive to the mold surface 
hydrophobicity, therefore a mold with low surface energy is extremely important for 
successful de-molding. 
The treated surface can be regularly cleaned after each imprint using most organic 
solvents, such as acetone or IP A, and be reused for next the imprint without retreating the 
surface. The treatment can also withstand a long period of time (up to 4 weeks) when 
stored in a dry box. If further cleaning is still needed, repeat step (2) in the procedure 
above, add more time if necessary, then stmi retreatment again from step (1). Retreatment 
is also necessary when the hydrophobicity of the mold surface is degrading from repeated 
imprinting, or naturally deteriorating. 
An alternative mold surface treatment without using proprietary products is to 
immerse the mold in 1% 1H,1H,2H,2H-perfluorodecyl-trichloro silane (FDTS) in n-
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heptane for 3 min, followed by subsequent washing with acetone and annealed at 110 oc 
for 10 minutes (Buyukserin et al. , 2009). 
4.4.2 Thermal and UV Imprinting 
Both thennal and UV imprinting will be demonstrated with PMMA and PEG-DA, 
respectively, on a silicon substrate, using a nanoimprinter (NX-B200, Nanonex, NJ), as 
shown in Figure 4-29. 
(A) 
[Figure 4-29: (A) Nanonex NX-B200 Full Wafer Nanoimprinter. (B) 2 inch wafer 
sample with a piece of mold on top ready for imprinting.] 
First, P AA sodium salt is diluted in water (2% w/v *) and spin coated on a pre-
cleaned silicon wafer at 3000 rpm for 40 seconds, then baked at 160 oc for 1 minute. The 
* Mass concentration, 1% w/v meaning 1 gram of solute dissolved in a final volume of 100 mL 
solution. 
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silicon wafer surface needs to be hydrophilic in order for the P AA spm coating to 
succeed. Tllis can be done by 02 plasma ashing with 300 seem gas flow and 300 W 
power for 1 0 minutes. P AA is used as both an adhesion promoting layer between the 
polymer and the substrate, and a release layer due to its switchable solubility in water 
(Linder, Gates, Ryan, Parviz, & Whitesides, 2005). Submerge the P AA coated substrate 
in 0.5 M calcium chloride (CaCb) for 5 minutes, wash with 50 mM CaCb, then with DI 
water will change it from water-soluble to water-insoluble. This process can subsequently 
be reversed by displacing the calcium ions with sodium (Na) ions (Figure 4-30) 
(Agarwal et al., 2012). 
j':>.CJ'/\ 
Soluble in Water Insoluble in Water 
[Figure 4-30: Reversible tuning of the solubility of P AA in water by exchanging 
between Ca2+ and Na + ions.] 
For thermal imprinting, PMMA (950 A4, MicroChem, MA) was spin coated onto 
the P AA coated Si wafer at 4000 rpm for 45 seconds. The imprinting process consisted of 
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four steps with these settings : (1) sample chamber pumping down for 3 minutes; (2) start 
pre-imprint process with 200 psi pressure, and increase temperature to 120 °C, above the 
glass transition temperature of PMMA; (3) start imprinting with 400 psi pressure and heat 
the sample to 170 °C, and hold for 3 minutes; (4) keep pressure constant until sample 
temperature is cooled down below 50 °C, then release the pressure. 
[Figure 4-31: (A-C) SEM images of several PMMA nanorods imprinted with the 
nanoporous hybrid mold with various size and shapes. (A) Average height ~250 nm, 
average diameter ~50 nm; (B) Average height ~300 nm, average diameter ~200 nm, 
average diameter ~30 nm; (C) Average height ~150 nm, average diameter ~50 nm with 
flat top. (D) Imprint sample surface showing a perfect replication of the mold, with the 
active imprint area and non-patterned area clearly visible.] 
PMMA imprinting results are shown in Figure 4-31. The shape of the mold was 
able to be completely replicated on PMMA, and the size and shape of the nanorods can 
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be controlled by the diameter and aspect ratio of the mold pattern, as well as the 
imprinting pressure. Of note, the imprinting temperature has to be well above the glass 
transition temperature of PMMA, which is around 1 OS °C, and the imprinting duration 
should not be kept for longer than S minutes to avoid the mold and the substrate 
becoming inseparable. 
[Figure 4-32: SEM images of several PEG-DA nanorods imprinted with the nanoporous 
hybrid mold with various size and shapes. (A) Average height ~ 70 nm, average diameter 
~40 nm;(B) Average height ~300 nm, average diameter ~200 nm, average diameter ~30 
nm; (C) Average height ~ 1SO nm, average diameter ~SO nm; (D) Average height ~ 1SO 
nm, average diameter ~SO nm.] 
Hydrogel precursor comprised of 80% PEG-DA (average Mw 2SO), 20% DI 
water, and an additional 1.S% photoinitiator was used for UV imprinting. Compared to 
PMMA, when spin coating hydrogel, it is much more difficult to achieve a uniform 
121 
thickness. The imprinting process is also different; instead of raising the temperature to 
up to 170 °C, UV imprinting temperatures are only slightly elevated above room 
temperature. Specifically, it consisted of five steps with these settings: (1) sample 
chamber pumping down for 3 minutes; (2) start p~e-imprint process with 200 psi pressure 
without changing the temperature; (3) start imprinting with 400 psi pressure and slight 
increase in heat to raise the sample temperature to 3 7 °C, and hold for 3 minutes; ( 4) keep 
pressure constant and turn on the UV lamp for 30 seconds; (5) turn off the UV light first 
before releasing the pressure. Imprinting results were satisfactory, as shown in Figure 4-
32, various size and shape of hydrogel nanorods were achieved as well. However, a flash 
layer still existed for the current experimental results. 
4.4.3 Particle Release 
With the presence of the flash layer as seen previously, the underlying P AA 
sodium salt layer could not be accessed so that the switchable water-solubility based 
release method was not explored at the time of writing this dissertation. Instead, using an 
ultra-fine razor blade, the imprinted nanorods were scraped off the substrate and collected 
in a micropipette. Then they were dropped onto another silicon wafer for SEM imaging, 
as shown in Figure 4-33. 
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-200nm ~----------~------~~ 
[Figure 4-33: SEM images showing freely released hydrogel nanorods with ~250 nm in 
length and ~40 run in diameter.] 
Nanorods with aspect ratios ranging from 3 to 10 can be achieved using the AAO 
template-assisted method repmied herein, and their elastic properties can be tuned based 
on the PEG-DA concentration as well as crosslinking parameters. So far, only 
preliminary particle release experiments were attempted. 
4.5 Summary and Discussion 
The approach presented herein represents a top-down, engineering approach for 
polymeric micro- and nanoparticles with strict control over particle size and shape, which 
can be used as a delivery vehicle for X-ray attenuating media for next-generation CT 
contrast agents, and possibly for other imaging modalities or drug delivery systems. It has 
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the potential to significantly increase vascular circulation times, improve sensitivity and 
disease specificity for certain imaging applications, afford multiplexing capability 
through the incorporation of various X-ray attenuating materials, as well as the potential 
for functional imaging and sensing with the use of alternative, environmentally 
responsive hydrogel structures. 
At the micro-scale, hydrogel particles carrying X-ray attenuating payloads were 
fabricated, their CT imaging capability were examined, and their mechanical properties 
were characterized, demonstrating superior tunable mechanical properties based on 
various parameters of the hydrogel fabrication process. At the nano-scale, a novel 
nanomanufacturing platform utilizing self-ordered nanoporous AAO membrane for 
fabricating size and shape specific polymeric nanorods, that is both scalable and cost-
efficient, was proposed and demonstrated. 
4.5.1 AAO Optimization 
As mentioned in 4.3.1, it 1s important during the segmented aluminum film 
deposition process that the finishing, or the top, of the aluminum layer must be done at a 
slow rate to ensure high quality. SEM images in Figure 4-34 show two samples with 
different initial Al film quality, as well as the drastically different end results after the 
same 3-step anodization process was carried out on these samples respectively. 
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[Figure 4-34: (A, C) SEM images of the surface of a low Al film quality sample before 
and after the 3-step anodization; (B, D) SEM images of another sample with higher Al 
film quality, taken at the same magnification as (A) and (C), respectively.] 
It is hypothesized that during the first anodization, the pores are formed at random 
locations with a tendency to occur along surface defects, seen as the black "cracks" in 
Figure 4-34 (A). These defect will become "magnified" after each anodization step and 
eventually develop into bigger defects causing the final AAO sample to be useless, since 
these "imperfections" will be getting even fmiher enhanced during the RIE patter transfer 
process. It is therefore crucial to ensure high quality Al films, especially at the initial 
anodization stage, in order to achieve uniform and homogeneous nanoporous structures. 
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4.5.2 Future Work 
Particle release based on the water solubility switchable P AA layer needs to be 
further explored, so that the high throughput potential of the proposed nanomanufacturing 
platform can be realized. Based on current experimental results, several hypothesis might 
be able to explain the presence of the flash layer, which prevents the utilization of the 
PAA-based release: (1) The thickness ofthe titanium is not enough (or this layer may be 
completely absent) due to etching from the AAO removal step. For this possibility, an 
alternative aluminum oxide etchant can be tried, such as H3P04; (2) Pore spacing is too 
small such that the UV light can still leak/scatter below the titanium layer and crosslink 
the polymer precursor underneath. In this case, increasing the anodization voltage or 
switching to a different electrolyte can increase the pore spacing in the AAO template, 
thereby increasing the pore spacing in the mold. 
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[Figure 4-35: X-ray attenuation properties ofiopamidol-370 and PEG-TaOx nanoparticle 
suspension at different relative concentrations and CT X-ray energy levels.] 
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In addition, X-ra¥ attenuating materials could be integrated into the hydrogel 
nanorod fabrication for CT validation. Figure 4-35 compares the X-ray attenuating 
properties of iodine (iopamidol-370) and tantalum oxide nanoparticles (chemically 
synthesized based on the protocol reported by M.H. Oh, et al.) (Oh et al. , 2011) at 
different CT X-ray energy levels. On one hand, this demonstrates one of the limitations 
of the current iodine-based CT contrast agents, with the X-ray attenuating capability 
decreasing significantly at the higher, more clinically relevant X-ray energy levels. On 
the other hand, it highlights the ,potential for multiplexed CT imaging, by using 
multispectral CT scan in which several energies of X-ray beams are emitted 
simultaneously, and the differences in the X-ray spectra allowing for material 
decomposition, thereby discriminating gold or tantalum oxide nanoparticles from iodine. 
A recent study reported using simultaneous multispectral CT imaging to differentiate an 
iodinated vascular agent from atherosclerotic plaque targeting gold nanoparticles (Kiyuk 
Chang et al., 2010). By utilizing a variety of X-ray attenuating materials in CT contrast 
agent design, simultaneous imaging of several agents using multispectral CT offers the 
potential to discriminate the various materials to realize multiplexed imaging using CT. 
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CHAPTERS 
CONCLUSION 
It is the purpose of this dissertation to highlight the importance of the rational 
design of particle systems using top-down engineering approaches, as well as the 
limitations in the current fabrication methods for size and shape specific particles. Other 
than particle size, other properties, including particle shape, mechanical property, surface 
property, etc., also have significant impact in determining how the particles will interact 
with the biological systems, such as the vascular circulation time, biodistribution, cellular 
internalization, and pharmacokinetics. However, a scalable, low cost and easily 
accessible manufacturing platform still needs to be developed in order to realize the full 
potential of micro- and nanoparticles in biomedical applications. 
In this dissertation, top-down approaches were employed in the rational design of 
two particle systems for their potential use as MRI and CT contrast agents, respectively. 
Specifically, the design, material characterization, particle fabrication and MRI validation 
of precisely engineered MRI contrast agents were reported. Reactively sputtered iron 
oxide thin films with controllable saturation magnetic polarization were employed in the 
top-down fabrication of two types of biocompatible MRI contrast agent 
micro/nanoparticles with geometry and magnetic property-dependent, tlmable MRI 
spectral signatures. This unique approach enables the possibility for multiplexed imaging 
in MRI, as well as a diffusion-driven signal amplification and the potential for 
functionalization. 
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In addition, a nanomanufacturing platform was proposed and demonstrated, 
which represents the top-down engineering approach for polymeric micro- and 
nanoparticles with strict control over particle size and shape that can be used as a delivery 
vehicle for X-ray attenuating media for next-generation CT contrast agents. At the micro-
scale, hydrogel particles carrying X-ray attenuating payloads were fabricated, their CT 
imaging capability were examined, and their mechanical properties were characterized, 
demonstrating superior tunable mechanical properties based on various parameters of the 
hydrogel fabrication process. At the nano-scale, a novel nanomanufacturing platform 
utilizing self-ordered nanoporous AAO membrane for fabricating size and shape specific 
polymeric nanorods, that is both scalable and cost-efficient, was proposed and 
demonstrated. 
The future work for both case studies has been outlined at both the end of Chapter 
3 and Chapter 4. 
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APPENDIX 
A.l Conversion of Units 
Symbol Gaussian & cgs emu Conversion 51 & rationalized mks (c) Quantity (a) Factor, C (b) 
Magnetic flux density, 
B .gauss (G) (d) 104 tcsla (f), Wb/m 2 
magnetic induction 
Magnetic flux cp ·maxwell (Mx), G·cm2 lO.s weber (Wb), volt second (V·s) 
Magnetic potential difference, 
U,F gilbert (Gb) 10/4n ampere (A) 
magnetomotive force 
Magnetic field strength, 
H 
oersted (Oe) (e), 
103/4n Nm(f) 
magnetizing force Gb/cm 
(Volume) magnetization (g) M emu/cm3 (h) 103 Nm 
(Volume) magnetization 4nM G 103/4n A/m 
Magnetic polarization, J, I emu/cm3 4nxl0'4 T, Wb/m2 (i) intensity of magnetization 
1 A·m2/kg 
:(Mass) magnetization a, M emu/g 
4nx10'7 W·bm/kg 
Magnetic moment m emu, erg/G 10-3 A·m2, joule per tesla (J/T) 
Magnetic dipole moment j emu, erg/G 4nx10'10 Wb·m (i) 
dimensionles, 4n dimensionless 
·(Volume) susceptibility x, ~e 
emu/cm3 (4n)2xl0'7 henry per meter (H/m), Wb/(A·m) 
(Mass) susceptibility cm3/g, emu/g 
4; xl0'3 mJ/kg 
xp, xp (4n)2xl0' 10 H·m2/kg 
(Molar) susceptibility xmol, em 3 /mol, emu/mol 4nx10'
6 
m
3/mol 
Kmol (4n)2x10'13 H-m2/mol 
Permeability fl dimensionless 4n><10'7 H/m, Wb/(A·m) 
Relative permeability G) FJT not defined dimensionless 
(Volume) energy density, 
w erg/cm3 w·l J/m3 
energy product (k) 
Demagnetization factor D, N . dimensionless 1/4n dimensionless 
(a) . Gaussian units and cgs emu are the same for magnetic properties. The defining 
relation is B = H + 4nM. 
(b). Multiply a number in Gaussian units by C to convert it to SI (e.g. , 1 G x 10-4 T/G = 
(c) . SI (Systeme International d 'Unites) has been adoptedby the National Bureau of 
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Standards. Where two conversion factors are given, the upper one is recognized 
under, or consistent with, SI and is based on the definition B = flo(H + M), where 
flO = 4n x 10-7 Him. The lower one is not recognized under SI and is based on the 
definition B = flOH + J, where the symbol I is often used in place of J. 
(d). 1 gauss= 105 gamma (y). 
(e). Both oersted and gauss are expressed as cm-112·g-112·s-1 in terms ofbase units. 
(f). Aim was often expressed as "ampere-turn per meter" when used for magnetic field 
strength. 
(g). Magnetic moment per unit volume. 
(h). The designation "emu" is not a unit. 
(i). Recognized under SI, even though based on the definition B = floH + J. See 
footnote (c). 
G). flr = fl / flO= 1 + x, all in Sl. flr is equal to Gaussian fl. 
(k) . B ·Hand flaM· H have SI units J/m3; M ·Hand B · H/4n have Gaussian units 
erg/cm3. 
Adapted from: 
R. B. Goldfarb and F. R. Fickett, US Department of Commerce, National Bureau of 
Standards, Boulder, Colorado 80303, March 1985 
NBS Special Publication 696 for sale by the Superintendent of Documents, U S. 
Government Printing Office, Washington, DC 20402 
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